Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

Articles published in
J Med Virol
    September 2024
  1. LIU D, Leung KY, Zhang R, Lam HY, et al
    Efficacy of molnupiravir and interferon for the treatment of SARS-CoV-2 in golden Syrian hamster.
    J Med Virol. 2024;96:e29901.
    >> Share

  2. WANG M, Zhang D, Lei T, Zhou Y, et al
    Interferon-responsive neutrophils and macrophages extricate SARS-CoV-2 Omicron critical patients from the nasty fate of sepsis.
    J Med Virol. 2024;96:e29889.
    >> Share

  3. PLUMERS R, Dreier J, Knabbe C, Vollmer T, et al
    Unexpected high incidence of parvovirus B19 nucleic acid detection in German blood donors in the winter/spring season 2023/2024.
    J Med Virol. 2024;96:e29878.
    >> Share

  4. HUNG HC, Tan BF, Lin WS, Wu SC, et al
    Glycan masking of NTD loops with a chimeric RBD of the spike protein as a vaccine design strategy against emerging SARS-CoV-2 Omicron variants.
    J Med Virol. 2024;96:e29893.
    >> Share

  5. ZHOU Y, Feng W, Yang C, Wei X, et al
    E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting proteasome-dependent degradation of NSP5.
    J Med Virol. 2024;96:e29891.
    >> Share

  6. LO VT, Lim HA, Jang SS, Kim MC, et al
    N121T and N121S substitutions on the SARS-CoV-2 spike protein impact on serum neutralization.
    J Med Virol. 2024;96:e29871.
    >> Share

  7. LI K, Chen S, Li Z, Shen Y, et al
    Epidemiological characterization of hand, foot, and mouth disease among hospitalized children from 2014 to 2023 in a hospital in Henan Province: Longitudinal surveillance study.
    J Med Virol. 2024;96:e29916.
    >> Share

  8. NOH HE, Rha MS, Jeong Y, Kim D, et al
    Differential regulation of viral entry-associated genes modulated by inflammatory cytokines in the nasal epithelium.
    J Med Virol. 2024;96:e29913.
    >> Share

  9. KARACHALIOU M, Ranzani O, Espinosa A, Iraola-Guzman S, et al
    Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19.
    J Med Virol. 2024;96:e29862.
    >> Share

  10. GAY L, Desquiret-Dumas V, Nagot N, Rapenne C, et al
    Long-term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: A review of mechanisms involved.
    J Med Virol. 2024;96:e29886.
    >> Share

    August 2024
  11. OUOBA S, Sugiyama A, Ko K, Mirzaev UK, et al
    Development of a unit conversion tool for five quantitative anti-spike assays and agreement analysis of three qualitative anti-nucleocapsid assays for SARS-CoV-2.
    J Med Virol. 2024;96:e29826.
    >> Share

  12. NKINDA L, Barabona G, Ngare I, Nkuwi E, et al
    Evaluation of cross-neutralizing immunity following COVID-19 primary series vaccination during the Omicron surge in Tanzania.
    J Med Virol. 2024;96:e29822.
    >> Share

  13. JIANG X, Gao X, Ding J, Pang B, et al
    Fecal microbiota transplantation alleviates mild-moderate COVID-19 associated diarrhoea and depression symptoms: A prospective study of a randomized, double-blind clinical trial.
    J Med Virol. 2024;96:e29812.
    >> Share

  14. GUPTA A, Righi E, Konnova A, Sciammarella C, et al
    Interleukin-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV.
    J Med Virol. 2024;96:e29820.
    >> Share

  15. GALUCIO VCA, de Menezes DC, Chaves ECR, van den Berg AVS, et al
    Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross-sectional study.
    J Med Virol. 2024;96:e29828.
    >> Share

  16. LI T, Li X, Lin F, Fu H, et al
    Epidemiology of the resurgence of respiratory syncytial virus infections among children post-COVID-19: A single-center retrospective observational study.
    J Med Virol. 2024;96:e29841.
    >> Share

  17. CHEN Y, Zhao X, Ye C, Zhou J, et al
    Epidemiology and viral loads of respiratory syncytial virus in hospitalized children prior to and during COVID-19 pandemic in Hangzhou, China.
    J Med Virol. 2024;96:e29855.
    >> Share

  18. TOMAR SS, Khairnar K
    Detection of lumpy skin disease virus reads in the human upper respiratory tract microbiome requires further investigation.
    J Med Virol. 2024;96:e29829.
    >> Share

  19. KOZAWA K, Higashimoto Y, Kawamura Y, Miura H, et al
    Temporal patterns of asymptomatic SARS-CoV-2 infection among pediatric population in Japan: A 3-year analysis.
    J Med Virol. 2024;96:e29847.
    >> Share

  20. SEEKIRCHER L, Astl M, Tschiderer L, Wachter GA, et al
    Anti-Spike IgG antibodies as correlates of protection against SARS-CoV-2 infection in the pre-Omicron and Omicron era.
    J Med Virol. 2024;96:e29839.
    >> Share

  21. KATONA M, Jeles K, Takacs P, Csoma E, et al
    DNA and seroprevalence study of MW and STL polyomaviruses.
    J Med Virol. 2024;96:e29860.
    >> Share

  22. SAKR AA, Mohamed AA, Ahmed AE, Abdelhaleem AA, et al
    Biochemical implication of acetylcholine, histamine, IL-18, and interferon-alpha as diagnostic biomarkers in hepatitis C virus, coronavirus disease 2019, and dual hepatitis C virus-coronavirus disease 2019 patients.
    J Med Virol. 2024;96:e29857.
    >> Share

  23. PIETROLUONGO E, Luciano A, Peddio A, Buonaiuto R, et al
    Exploring the interplay between Kaposi's sarcoma and SARS-CoV-2 infection: A case series and systematic review.
    J Med Virol. 2024;96:e29849.
    >> Share

  24. GARCIA-VEGA M, Llamas-Covarrubias MA, Loza M, Resendiz-Sandoval M, et al
    Single-cell transcriptomic analysis of B cells reveals new insights into atypical memory B cells in COVID-19.
    J Med Virol. 2024;96:e29851.
    >> Share

  25. BINAYKE A, Zaheer A, Vishwakarma S, Sharma P, et al
    Understanding the landscape of the SARS-CoV-2-specific T cells post-omicron surge.
    J Med Virol. 2024;96:e29877.
    >> Share

  26. PONTIROLI AE, Zanoni I, Tanzi E, Tagliabue E, et al
    Effect of influenza vaccination on SARS-CoV-2 infection: Relationship between SARS-CoV-2 infection rates and effects of influenza vaccination.
    J Med Virol. 2024;96:e29868.
    >> Share

  27. ZHAO XJ, Liu XL, Gu HJ, Liu T, et al
    SARS-CoV-2 reinfection broadens the antibody responses and promotes the phenotypic differentiation of virus-specific memory T cells in adolescents.
    J Med Virol. 2024;96:e29873.
    >> Share

  28. MAES M, Almulla AF, Tang X, Stoyanova K, et al
    From human herpes virus-6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID.
    J Med Virol. 2024;96:e29864.
    >> Share

  29. THIERRY AR, Salmon D
    Inflammation-, immunothrombosis,- and autoimmune-feedback loops may lead to persistent neutrophil self-stimulation in long COVID.
    J Med Virol. 2024;96:e29887.
    >> Share

  30. KITANO T, Kitagawa D, Murata M, Onishi M, et al
    Duration of PCR positivity by type of respiratory virus among children using a multiplex PCR test.
    J Med Virol. 2024;96:e29890.
    >> Share

    July 2024
  31. GALLEGO-GARCIA P, Estevez-Gomez N, De Chiara L, Alvarino P, et al
    Dispersal history of SARS-CoV-2 in Galicia, Spain.
    J Med Virol. 2024;96:e29773.
    >> Share

  32. VOLCIC M, Nchioua R, Pastorio C, Zech F, et al
    Attenuated replication and damaging effects of SARS-CoV-2 Omicron variants in an intestinal epithelial barrier model.
    J Med Virol. 2024;96:e29783.
    >> Share

  33. MEI HE, Schulz AR, Hirseland H, Diekmann LM, et al
    Prophylactic antibodies inhibit spike-specific T and B cell responses after COVID-19 vaccination.
    J Med Virol. 2024;96:e29778.
    >> Share

  34. KAO CL, Liu PH
    Comment on "A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination".
    J Med Virol. 2024;96:e29785.
    >> Share

  35. LOPEZ-AYLLON BD, Marin S, Fernandez MF, Garcia-Garcia T, et al
    Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10.
    J Med Virol. 2024;96:e29752.
    >> Share

  36. CARRETERO D, Gimenez E, Albert E, Colomer E, et al
    SARS-CoV-2-Spike T-cell response after receiving one or two Wuhan-Hu-1-based mRNA COVID-19 vaccine booster doses in elderly nursing home residents.
    J Med Virol. 2024;96:e29790.
    >> Share

  37. LEE S, Lee K, Park J, Jeong YD, et al
    Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023: A comprehensive analysis of the international pharmacovigilance database.
    J Med Virol. 2024;96:e29792.
    >> Share

  38. DECKER SRDR, Wolf JM, Pille A, Freese L, et al
    Temporal trends in respiratory pathogens following the COVID-19 pandemic and climate variables: A unicentric retrospective evaluation of 24 pathogens in a temperate subtropical region.
    J Med Virol. 2024;96:e29797.
    >> Share

  39. SPRINGER DN, Camp JV, Aberle SW, Deutsch J, et al
    Neutralization of SARS-CoV-2 Omicron XBB.1.5 and JN.1 variants after COVID-19 booster-vaccination and infection.
    J Med Virol. 2024;96:e29801.
    >> Share

  40. GAY L, Madariaga Zarza S, Abou Atmeh P, Rouviere MS, et al
    Protective role of macrophages from maternal-fetal interface in unvaccinated coronavirus disease 2019 pregnant women.
    J Med Virol. 2024;96:e29819.
    >> Share

  41. REINIG S, Kuo C, Wu CC, Huang SY, et al
    Specific long-term changes in anti-SARS-CoV-2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines.
    J Med Virol. 2024;96:e29793.
    >> Share

  42. SHEN Z, Li Q, Wu J, Zhu D, et al
    Dynamic evolution of COVID-19 vaccine hesitancy over 2021-2023 among Chinese population: Repeated nationwide cross-sectional study.
    J Med Virol. 2024;96:e29800.
    >> Share


  43. Correction to [A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus].
    J Med Virol. 2024;96:e29803.
    >> Share

  44. LI S, Bu J, Pan X, Li Q, et al
    SARS-CoV-2 envelope protein-derived extracellular vesicles act as potential media for viral spillover.
    J Med Virol. 2024;96:e29782.
    >> Share

  45. CENAT JM, Moshirian Farahi SMM, Dalexis RD, Caulley L, et al
    COVID-19 vaccine mistrust, health literacy, conspiracy theories, and racial discrimination among a representative ethnically diverse sample in Canada: The vulnerability of Arab, Asian, Black, and Indigenous peoples.
    J Med Virol. 2024;96:e29795.
    >> Share

    June 2024
  46. JEONG YD, Lee K, Lee S, Park J, et al
    Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database.
    J Med Virol. 2024;96:e29682.
    >> Share

  47. CHEN IW, Yu TS, Lin CH, Hung KC, et al
    Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19: A meta-regression analysis.
    J Med Virol. 2024;96:e29718.
    >> Share

  48. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    Antibiotics in COVID-19: Unveiling disturbing truths through critical scrutiny.
    J Med Virol. 2024;96:e29720.
    >> Share

  49. HAN Y, Ma Y, Wang Z, Feng F, et al
    TMPRSS13 promotes the cell entry of swine acute diarrhea syndrome coronavirus.
    J Med Virol. 2024;96:e29712.
    >> Share

  50. BORGOGNA C, Ferrante D, Rosso G, Guglielmetti G, et al
    A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS-CoV-2 mRNA vaccine.
    J Med Virol. 2024;96:e29710.
    >> Share

  51. PAVIA G, Quirino A, Marascio N, Veneziano C, et al
    Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
    J Med Virol. 2024;96:e29708.
    >> Share

  52. SONG K, Ye RZ, Li YY, Gong C, et al
    A Statovirus-like virus from respiratory tracts of patients, China.
    J Med Virol. 2024;96:e29711.
    >> Share

  53. XIONG X, Zheng Z, Liu C, Wang X, et al
    Unveiling the metabolic and coagulation disruptions in SARS-CoV-2-associated acute macular neuroretinopathy: A case-control study.
    J Med Virol. 2024;96:e29714.
    >> Share

  54. JURKOWICZ M, Cohen H, Nemet I, Keller N, et al
    Epidemiological and clinical characteristics of hospitalized human metapneumovirus patients in Israel, 2015-2021: A retrospective cohort study.
    J Med Virol. 2024;96:e29709.
    >> Share

  55. SAADE A, Didier Q, Cha L, Garlantezec R, et al
    The prevalence, determinants, and consequences of post-COVID in healthcare workers: A cross-sectional survey.
    J Med Virol. 2024;96:e29725.
    >> Share

  56. KIM H, Kyung S, Park J, Lee H, et al
    Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK.
    J Med Virol. 2024;96:e29740.
    >> Share

  57. AGUILAR R, Jimenez A, Santano R, Vidal M, et al
    Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings.
    J Med Virol. 2024;96:e29713.
    >> Share

  58. SHI P, Wang R, Liu E, Deng Y, et al
    Timing patterns of initial respiratory syncytial virus infection and factors influencing disease severity in hospitalized infants with different health status.
    J Med Virol. 2024;96:e29719.
    >> Share

  59. LEE S, Jo H, Lee H, Lee H, et al
    Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database.
    J Med Virol. 2024;96:e29693.
    >> Share

  60. BLANGY-LETHEULE A, Vergnaud A, Dupas T, Habert D, et al
    Value of a secretomic approach for distinguishing patients with COVID-19 viral pneumonia among patients with respiratory distress admitted to intensive care unit.
    J Med Virol. 2024;96:e29756.
    >> Share

  61. ALMANZAR G, Koosha K, Vogt T, Stein A, et al
    Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2.
    J Med Virol. 2024;96:e29739.
    >> Share

  62. TANG Y, Zou X, Liu P, Dai Y, et al
    Human umbilical cord-derived mesenchymal stem cell transplantation improves the long COVID.
    J Med Virol. 2024;96:e29757.
    >> Share

  63. KARBIENER M, Kindle G, Meyts I, Seppanen MRJ, et al
    Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.
    J Med Virol. 2024;96:e29738.
    >> Share

  64. ZHU W, Gu L
    Resurgence of seasonal influenza driven by A/H3N2 and B/Victoria in succession during the 2023-2024 season in Beijing showing increased population susceptibility.
    J Med Virol. 2024;96:e29751.
    >> Share

  65. MALLICK A, Sukla S, De A, Biswas S, et al
    Evidences support that dengue virus can impart broad-spectrum immunity against betacoronaviruses in dengue endemic regions.
    J Med Virol. 2024;96:e29771.
    >> Share

  66. XIAO M, Banu A, Jia Y, Chang M, et al
    Circulation pattern and genetic variation of rhinovirus infection among hospitalized children on Hainan Island, before and after the dynamic zero-COVID policy, from 2021 to 2023.
    J Med Virol. 2024;96:e29755.
    >> Share

    May 2024
  67. HSU AY, Lin CJ, Hsia NY, Wang YH, et al
    Reply to comment on "The risk assessment of uveitis after COVID-19 diagnosis by Wu et al. 2024".
    J Med Virol. 2024;96:e29636.
    >> Share

  68. HEWEL C, Schmidt H, Runkel S, Kohnen W, et al
    Nanopore adaptive sampling of a metagenomic sample derived from a human monkeypox case.
    J Med Virol. 2024;96:e29610.
    >> Share

  69. ZHAO XJ, Liu XL, Liang YM, Zhang S, et al
    Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China.
    J Med Virol. 2024;96:e29640.
    >> Share

  70. TANG Z, Mao Y, Ruan P, Li J, et al
    Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses.
    J Med Virol. 2024;96:e29643.
    >> Share

  71. MATUSALI G, Mazzotta V, Meschi S, Colavita F, et al
    JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in healthcare workers and people with HIV.
    J Med Virol. 2024;96:e29631.
    >> Share

  72. GAO R, Feng C, Sheng Z, Li F, et al
    Research progress in Fc-effector functions against SARS-CoV-2.
    J Med Virol. 2024;96:e29638.
    >> Share

  73. WANG F, Gao Y, Wagner AL, Lu Y, et al
    A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination.
    J Med Virol. 2024;96:e29629.
    >> Share

  74. THOMAS S, Smatti MK, Alsulaiti H, Zedan HT, et al
    Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigens.
    J Med Virol. 2024;96:e29628.
    >> Share

  75. FENG Y, Zhao X, Chen Z, Wu Y, et al
    Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021-2022.
    J Med Virol. 2024;96:e29664.
    >> Share

  76. ISHII T, Nawa N, Hosokawa S, Morio T, et al
    Exploring viral infections' role in Kawasaki disease onset: A study during the COVID-19 pandemic.
    J Med Virol. 2024;96:e29660.
    >> Share

  77. ASHOKKUMAR S, Lim JS, Kaushik NK, Han I, et al
    Human coronavirus 229E inactivation on porous and nonporous materials using dielectric barrier discharge (DBD) plasma.
    J Med Virol. 2024;96:e29655.
    >> Share

  78. WU JY, Chen CC, Liu MY, Hsu WH, et al
    Clinical effectiveness of nirmatrelvir plus ritonavir on the short- and long-term outcome in high-risk children with COVID-19.
    J Med Virol. 2024;96:e29662.
    >> Share

  79. CHENG P, Zhai K, Han W, Zeng J, et al
    Characterizing the antigenic evolution of pandemic influenza A (H1N1) pdm09 from 2009 to 2023.
    J Med Virol. 2024;96:e29657.
    >> Share

  80. CHEN SY, Hsieh TYJ, Hung YM, Oh JW, et al
    Prior COVID-19 vaccination and reduced risk of cerebrovascular diseases among COVID-19 survivors.
    J Med Virol. 2024;96:e29648.
    >> Share

  81. RZYMSKI P, Zarebska-Michaluk D, Parczewski M, Genowska A, et al
    The burden of infectious diseases throughout and after the COVID-19 pandemic (2020-2023) and Russo-Ukrainian war migration.
    J Med Virol. 2024;96:e29651.
    >> Share

  82. GRUBER CEM, Tucci FG, Giombini E, Mazzotta V, et al
    Molnupiravir increases SARS-CoV-2 genome diversity and complexity: A case-control cohort study.
    J Med Virol. 2024;96:e29642.
    >> Share

  83. KYUNG S, Son Y, Kim M, Kang J, et al
    Risks of alopecia areata in long COVID: Binational population-based cohort studies from South Korea and Japan.
    J Med Virol. 2024;96:e29668.
    >> Share

  84. FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Ruiz-Ruigomez M, Arrieta-Ortubay E, et al
    Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms 2 years after hospitalization: The VIPER study.
    J Med Virol. 2024;96:e29676.
    >> Share

  85. QIAO H, Deng X, Qiu L, Qu Y, et al
    SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice.
    J Med Virol. 2024;96:e29671.
    >> Share

  86. DAMODAR T, Dunai C, Prabhu N, Jose M, et al
    Diagnostic markers of acute encephalitis syndrome and COVID-associated multisystem inflammatory syndrome in children from Southern India.
    J Med Virol. 2024;96:e29666.
    >> Share

  87. HAQUE W, Talha M, Rahman S, Hasan M, et al
    Rotavirus trends and distribution of genotypes before and during COVID-19 pandemic era: Bangladesh, 2017-2021.
    J Med Virol. 2024;96:e29681.
    >> Share

  88. AMOROSO MG, Pucciarelli A, Serra F, Ianiro G, et al
    Ten different viral agents infecting and co-infecting children with acute gastroenteritis in Southern Italy: Role of known pathogens and emerging viruses during and after COVID-19 pandemic.
    J Med Virol. 2024;96:e29679.
    >> Share

  89. GONG S, Ma C, Ma R, Zhu T, et al
    Elevated pretreatment serum apolipoprotein E level associated with poor prognosis of patients with COVID-19 during the omicron BA.5 and BF.7 wave.
    J Med Virol. 2024;96:e29673.
    >> Share

  90. AKANCHISE T, Angelov B, Angelova A
    Nanomedicine-mediated recovery of antioxidant glutathione peroxidase activity after oxidative-stress cellular damage: Insights for neurological long COVID.
    J Med Virol. 2024;96:e29680.
    >> Share

    April 2024
  91. GUNGOR K, Bukavaz S, Ekuklu G
    Measles outbreak in the adult age group: Clinical, laboratory, and epidemiological features of the 11 patients admitted to the hospital.
    J Med Virol. 2024;96:e29583.
    >> Share

  92. HE S, Liu SQ, Teng XY, He JY, et al
    Comparative single-cell RNA sequencing analysis of immune response to inactivated vaccine and natural SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29577.
    >> Share

  93. WOO HG, Kim HJ, Park J, Lee J, et al
    Global burden of vaccine-associated multiple sclerosis, 1967-2022: A comprehensive analysis of the international pharmacovigilance database.
    J Med Virol. 2024;96:e29591.
    >> Share

  94. GANDIKOTA C, Vaddadi K, Sivasami P, Huang C, et al
    The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses.
    J Med Virol. 2024;96:e29579.
    >> Share

  95. YANG H, Guan L, Yang T, Ma H, et al
    Two- and 3-year outcomes in convalescent individuals with COVID-19: A prospective cohort study.
    J Med Virol. 2024;96:e29566.
    >> Share

  96. MELE D, Ottolini S, Lombardi A, Conteianni D, et al
    Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccination.
    J Med Virol. 2024;96:e29585.
    >> Share

  97. FAN Y, Huang S, Wu D, Chu M, et al
    Immune features revealed by single-cell RNA and single-cell TCR/BCR sequencing in patients with rheumatoid arthritis receiving COVID-19 booster vaccination.
    J Med Virol. 2024;96:e29573.
    >> Share

  98. HUNG KC, Yu TS, Wang KF, Chen IW, et al
    Influenza vaccination on SARS-CoV-2 infection risk: A subgroup analysis on geographic factor.
    J Med Virol. 2024;96:e29576.
    >> Share

  99. ARUNAN B, Talukdar D, Swain S, Varadarajan A, et al
    Metagenomic insights into fungal community composition of the nasopharyngeal region of COVID-19 associated mucormycosis patients from India.
    J Med Virol. 2024;96:e29601.
    >> Share

  100. LI Y, Yu J, Wang Y, Yi J, et al
    Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: A retrospective study.
    J Med Virol. 2024;96:e29602.
    >> Share

  101. PARK D, Kim SM, Jang H, Kim K, et al
    Differential beta-coronavirus infection dynamics in human bronchial epithelial organoids.
    J Med Virol. 2024;96:e29600.
    >> Share

  102. SVIERCZ F, Jarmoluk P, Godoy Coto J, Cevallos C, et al
    The abortive SARS-CoV-2 infection of osteoclast precursors promotes their differentiation into osteoclasts.
    J Med Virol. 2024;96:e29597.
    >> Share

  103. RAI P, Marano JM, Kang L, Coutermarsh-Ott S, et al
    Obesity fosters severe disease outcomes in a mouse model of coronavirus infection associated with transcriptomic abnormalities.
    J Med Virol. 2024;96:e29587.
    >> Share

  104. KURYLOWICZ A, Babicki M, Wasowski M, Jankowski P, et al
    Triglicerydes/high-density lipoprotein ratio as a risk factor of post-Covid-19 sinus tachycardia: A retrospective study.
    J Med Virol. 2024;96:e29586.
    >> Share

  105. YE G, Tang Y, Yang Q, Zhang C, et al
    A peptide derived from SARS-CoV-2 nucleocapsid protein with broad-spectrum anti-coronavirus activity.
    J Med Virol. 2024;96:e29492.
    >> Share

  106. MENG H, Wang Y, Zhai Y, Luo W, et al
    Unveiling the micronutrient-immunity puzzle in inactivated COVID-19 vaccination: A comprehensive analysis of circulating micronutrient levels and humoral responses in healthy adults.
    J Med Virol. 2024;96:e29611.
    >> Share

  107. MAHLA RS, Dustin LB
    COVID-19 vaccination and autoimmunity: Do we need more evidence?
    J Med Virol. 2024;96:e29623.
    >> Share

  108. WEI M, Li S, Lu X, Hu K, et al
    Changing respiratory pathogens infection patterns after COVID-19 pandemic in Shanghai, China.
    J Med Virol. 2024;96:e29616.
    >> Share

  109. OKITSU S, Khamrin P, Hikita T, Onda Y, et al
    Remarkable increase in the detection and molecular characterization of adenovirus F41 in children with acute gastroenteritis in Japan, 2017-2023.
    J Med Virol. 2024;96:e29615.
    >> Share

  110. MATUSALI G, Vergori A, Cimini E, Mariotti D, et al
    Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV.
    J Med Virol. 2024;96:e29598.
    >> Share

  111. CHEN IW, Weng HL, Lai YC, Hung KC, et al
    Incidence of fatigue 2 years after SARS-CoV-2 infection: An updated meta-analysis and subgroup analysis.
    J Med Virol. 2024;96:e29619.
    >> Share

  112. DESTREMAU M, Chaussade H, Hemar V, Beguet M, et al
    Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: A retrospective multicenter study.
    J Med Virol. 2024;96:e29603.
    >> Share

  113. SUN Q, Gao J, An R, Wang M, et al
    Probing molecular pathways: Illuminating the connection between COVID-19 and Alzheimer's disease through the endocannabinoid system dynamics.
    J Med Virol. 2024;96:e29590.
    >> Share

  114. SONG G, Li R, Cheng MQ
    Safety, immunogenicity, and protective effective of inhaled COVID-19 vaccines: A systematic review and meta-analysis.
    J Med Virol. 2024;96:e29625.
    >> Share

    March 2024
  115. ZHANG N, Ye Z, Li C, Zhou J, et al
    A subunit-based influenza/SARS-CoV-2 Omicron combined vaccine induced potent protective immunity in BALB/c mice.
    J Med Virol. 2024;96:e29479.
    >> Share

  116. XIAO J, Luo Y, Li Y, Yao X, et al
    The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccinated volunteers.
    J Med Virol. 2024;96:e29488.
    >> Share

  117. WU P, Yii CY, Yong SB
    Comment on "The risk assessment of uveitis after COVID-19 diagnosis".
    J Med Virol. 2024;96:e29494.
    >> Share

  118. CHEN IW, Lin HJ, Lin YT, Hung KC, et al
    Comment on "The association of sickle cell disorder with adverse outcomes in COVID-19 patients: A meta-analysis".
    J Med Virol. 2024;96:e29495.
    >> Share

  119. LIU Y, Li M, Cui T, Chen Z, et al
    A superior heterologous prime-boost vaccination strategy against COVID-19: A bivalent vaccine based on yeast-derived RBD proteins followed by a heterologous vaccine.
    J Med Virol. 2024;96:e29454.
    >> Share

  120. KIM JW, Lee JH, Kim HJ, Heo K, et al
    Empowering SARS-CoV-2 variant neutralization with a bifunctional antibody engineered with tandem heptad repeat 2 peptides.
    J Med Virol. 2024;96:e29506.
    >> Share

  121. ZHANG R, Yan H, Zhou J, Yan G, et al
    Improved fluorescence-based assay for rapid screening and evaluation of SARS-CoV-2 main protease inhibitors.
    J Med Virol. 2024;96:e29498.
    >> Share

  122. XIONG N, Sun Q
    Identifying COVID-19 subtypes by single-sample gene set enrichemnt analysis and providing guidance for sensitive drug selection.
    J Med Virol. 2024;96:e29497.
    >> Share

  123. WU N, Chen Z, Zha G, Deng Z, et al
    Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China.
    J Med Virol. 2024;96:e29493.
    >> Share


  124. Retraction: "Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial".
    J Med Virol. 2024;96:e29509.
    >> Share


  125. Correction to "Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting".
    J Med Virol. 2024;96:e29518.
    >> Share

  126. ZHENG Y, Feng J, Song Y, Yu Y, et al
    Design and synthesis of APN and 3CLpro dual-target inhibitors based on STSBPT with anticoronavirus activity.
    J Med Virol. 2024;96:e29512.
    >> Share

  127. ROJO-ALBA S, Martinez ZP, Gonzalez-Alba JM, Boga JA, et al
    Respiratory syncytial virus incidence and typing in the last six seasons in the north of Spain (Asturias). Genetic characterization during the SARS-CoV-2 pandemic.
    J Med Virol. 2024;96:e29499.
    >> Share

  128. YEH LT, Chan CH, Wang YH, Lee CY, et al
    Exploring the incidence of peripheral arterial occlusive disease following COVID-19 infection: A retrospective cohort study.
    J Med Virol. 2024;96:e29519.
    >> Share

  129. TAI CG, Haviland MJ, Kissler SM, Lucia RM, et al
    Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball Association.
    J Med Virol. 2024;96:e29505.
    >> Share

  130. LEE C, Greenwood DC, Master H, Balasundaram K, et al
    Prevalence of orthostatic intolerance in long covid clinic patients and healthy volunteers: A multicenter study.
    J Med Virol. 2024;96:e29486.
    >> Share

  131. ROBERTS SC, Jolley SE, Beaty LE, Aggarwal NR, et al
    Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19.
    J Med Virol. 2024;96:e29541.
    >> Share

  132. DE AGUIRRE PM, Carlos S, Pina-Sanchez M, Mbikayi S, et al
    High pre-Delta and early-Omicron SARS-CoV-2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo).
    J Med Virol. 2024;96:e29529.
    >> Share

  133. TRANTER E, Frentsch M, Hutter-Kronke ML, Vuong GL, et al
    Comparable CD8(+) T-cell responses to SARS-CoV-2 vaccination in single-cell transcriptomics of recently allogeneic transplanted patients and healthy individuals.
    J Med Virol. 2024;96:e29539.
    >> Share

  134. ZHOU J, Zhou Y, Wei XF, Fan L, et al
    TRIM6 facilitates SARS-CoV-2 proliferation by catalyzing the K29-typed ubiquitination of NP to enhance the ability to bind viral genomes.
    J Med Virol. 2024;96:e29531.
    >> Share

  135. JITOBAOM K, Peerapen P, Boonyuen U, Meewan I, et al
    Identification of inositol monophosphatase as a broad-spectrum antiviral target of ivermectin.
    J Med Virol. 2024;96:e29552.
    >> Share

  136. HUANG M, Cui T, Liu S, Su X, et al
    Blended BA.5 infection within 8 days after a boosted bivalent mRNA vaccination strengthens and lengthens the host immunity.
    J Med Virol. 2024;96:e29544.
    >> Share

  137. ZHANG H, Guo H
    Optimization of a DNA-launched SARS-CoV-2 replicon with RNA splicing inhibitor Isoginkgetin.
    J Med Virol. 2024;96:e29547.
    >> Share

  138. ZHA G, Chen Z, Wu N, Huang T, et al
    Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study.
    J Med Virol. 2024;96:e29548.
    >> Share

  139. KUO YM, Kang CM, Lai ZY, Huang TY, et al
    Temporal changes in biomarkers of neutrophil extracellular traps and NET-promoting autoantibodies following adenovirus-vectored, mRNA, and recombinant protein COVID-19 vaccination.
    J Med Virol. 2024;96:e29556.
    >> Share

  140. ZEDAN HT, Smatti MK, Al-Sadeq DW, Al Khatib HA, et al
    SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.
    J Med Virol. 2024;96:e29527.
    >> Share

  141. FU X, Wang Z, Chen B, Sun H, et al
    Detection of SARS-CoV-2 virus in middle ear effusions and its association with otitis media with effusion.
    J Med Virol. 2024;96:e29545.
    >> Share

  142. FROHLICH GC, Gregianini TS, Pinheiro FG, Nascimento R, et al
    Resurgence of human respiratory syncytial virus during COVID-19 pandemic in Southern Brazil.
    J Med Virol. 2024;96:e29551.
    >> Share

  143. HUNG KC, Lin HJ, Chen IW
    New-onset neurodegenerative diseases following SARS-CoV-2 infection: An analysis of prediction interval.
    J Med Virol. 2024;96:e29563.
    >> Share

  144. WANG A
    Integrating Frechet distance and AI reveals the evolutionary trajectory and origin of SARS-CoV-2.
    J Med Virol. 2024;96:e29557.
    >> Share

  145. HUANG J, Qiu Y, Luo L, Wu J, et al
    Long-term immunogenicity and safety of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants who had received two or three doses of inactivated vaccine.
    J Med Virol. 2024;96:e29542.
    >> Share

  146. BROGNA C, Montano L, Zanolin ME, Bisaccia DR, et al
    A retrospective cohort study on early antibiotic use in vaccinated and unvaccinated COVID-19 patients.
    J Med Virol. 2024;96:e29507.
    >> Share

  147. ZHENG L, Wang H, Liu X, Xu C, et al
    A panel of multivalent nanobodies broadly neutralizing Omicron subvariants and recombinant.
    J Med Virol. 2024;96:e29528.
    >> Share

  148. OGUNJINMI OD, Abdullahi T, Somji RA, Bevan CL, et al
    The antiviral potential of the antiandrogen enzalutamide and the viral-androgen signaling interplay in seasonal coronaviruses.
    J Med Virol. 2024;96:e29540.
    >> Share

  149. ZHENG Z, Wu H, Sun X, Lu Y, et al
    Evaluation of the effectiveness and safety of sequential vaccination with inactivated SARS-CoV-2 vaccine and Ad5-nCoV booster in pediatric liver transplant recipients.
    J Med Virol. 2024;96:e29543.
    >> Share

  150. FARAONE JN, Wang X, Qu P, Zheng YM, et al
    Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination.
    J Med Virol. 2024;96:e29520.
    >> Share

    February 2024
  151. LIU P, Xing Z, Peng X, Zhang M, et al
    Machine learning versus multivariate logistic regression for predicting severe COVID-19 in hospitalized children with Omicron variant infection.
    J Med Virol. 2024;96:e29447.
    >> Share

  152. ANGUINZE RS, Toure A, Cisse F, Grayo S, et al
    Viral etiology of measles-like rash in Guinean children during the COVID epidemic in 2022.
    J Med Virol. 2024;96:e29437.
    >> Share

  153. CHEN Y, Liu X, Zhaohui T
    Reply to: Inspiratory muscle training for COVID-19: Benefits appear promising but findings remain uncertain.
    J Med Virol. 2024;96:e29441.
    >> Share

  154. CAMPS-VILARO A, Pinsach-Abuin ML, Degano IR, Ramos R, et al
    Genetic characteristics involved in COVID-19 severity. The CARGENCORS case-control study and meta-analysis.
    J Med Virol. 2024;96:e29404.
    >> Share

  155. VIRTANEN J, Korhonen EM, Salonen S, Vapalahti O, et al
    SARS-CoV-2 infections among pregnant women, 2020, Finland-Cross-testing of neutralization assays.
    J Med Virol. 2024;96:e29415.
    >> Share

  156. SOUZA MS, Farias JP, Andreata-Santos R, Silva MP, et al
    Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future.
    J Med Virol. 2024;96:e29416.
    >> Share

  157. HE M, Cao L, Liu L, Jin X, et al
    Reconstitution of RNA cap methylation reveals different features of SARS-CoV-2 and SARS-CoV methyltransferases.
    J Med Virol. 2024;96:e29411.
    >> Share

  158. SELVAVINAYAGAM ST, Suvaithenamudhan S, Yong YK, Hemashree K, et al
    Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal study.
    J Med Virol. 2024;96:e29456.
    >> Share

  159. CHANG LC, Chen IW, Hung KC
    Additional analyses support superior efficacy of nirmatrelvir/ritonavir over molnupiravir for COVID-19.
    J Med Virol. 2024;96:e29464.
    >> Share

  160. PASSOS V, Henkel LM, Wang J, Zapatero-Belinchon FJ, et al
    Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons.
    J Med Virol. 2024;96:e29455.
    >> Share

  161. NEDELCU I, Florian P, Ion D, Militaru E, et al
    Dynamics of serum cross-neutralization capacity against SARS-CoV-2 Delta variant in convalescent COVID-19 patients.
    J Med Virol. 2024;96:e29448.
    >> Share

  162. GAN M, Cao J, Zhang Y, Fu H, et al
    Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity.
    J Med Virol. 2024;96:e29452.
    >> Share

  163. COLSON P, Delerce J, Pontarotti P, Devaux C, et al
    Resistance-associated mutations to the anti-SARS-CoV-2 agent nirmatrelvir: Selection not induction.
    J Med Virol. 2024;96:e29462.
    >> Share

  164. SADAT LARIJANI M, Javadi A, Eskandari SE, Doroud D, et al
    The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID-19 vaccine regimens.
    J Med Virol. 2024;96:e29438.
    >> Share

  165. CENAT JM, Farahi SMMM, Dalexis RD, Yaya S, et al
    COVID-19 vaccine uptake, conspiracy theories, and health literacy among Black individuals in Canada: Racial discrimination, confidence in health, and COVID-19 stress as mediators.
    J Med Virol. 2024;96:e29467.
    >> Share

  166. KWOK KO, Wei WI, Mcneil EB, Tang A, et al
    Comparative analysis of symptom profile and risk of death associated with infection by SARS-CoV-2 and its variants in Hong Kong.
    J Med Virol. 2024;96:e29326.
    >> Share

  167. KIM D, Kim M, Kim J, Baek K, et al
    A mouse xenograft long-term replication yields a SARS-CoV-2 Delta mutant with increased lethality.
    J Med Virol. 2024;96:e29459.
    >> Share

  168. ZHAN H, Xie Y, Liu Y, Cheng L, et al
    Omicron BA.4/5 neutralization and cell-mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: A follow-up cohort study.
    J Med Virol. 2024;96:e29446.
    >> Share

  169. GAN J, Zhang H, Wu J, Liu Y, et al
    Effect of inactivated vaccine boosters against severe and critical COVID-19 during the Omicron BA.5 wave: A retrospective analysis of hospitalized patients in China.
    J Med Virol. 2024;96:e29402.
    >> Share

  170. CHIRUMBOLO S, Tirelli U
    On coming back, the scaring COVID-19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS-CoV2 spreading.
    J Med Virol. 2024;96:e29490.
    >> Share

  171. OMBELET S, Castanares-Zapatero D, Desimpel F, Hulstaert F, et al
    Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron: An updated meta-analysis.
    J Med Virol. 2024;96:e29434.
    >> Share

  172. YANG D, Chan JF, Yoon C, Luk TY, et al
    Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways.
    J Med Virol. 2024;96:e29472.
    >> Share

    January 2024
  173. PALOMINO-CABRERA R, Tejerina F, Molero-Salinas A, Veintimilla C, et al
    No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir.
    J Med Virol. 2024;96:e29337.
    >> Share

  174. ALESSANDRI F, d'Ettorre G, Ciccozzi M, Migliara G, et al
    Early recognition of a superinfection: This is the problem in the critically ill COVID-19 patients.
    J Med Virol. 2024;96:e29345.
    >> Share

  175. QI F, Cao Y, Shen Y, Wang H, et al
    Nasopharyngeal neutrophilic-retention signatures could predict disease progression in early SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29328.
    >> Share

  176. LI C, Ye G, Jiang Y, Wang Z, et al
    Artificial Intelligence in battling infectious diseases: A transformative role.
    J Med Virol. 2024;96:e29355.
    >> Share

  177. KIM MJ, Park PG, Hwang SJ, Bang SJ, et al
    Saliva-based Proteinase K method: A rapid and reliable diagnostic tool for the detection of SARS-COV-2 in children.
    J Med Virol. 2024;96:e29361.
    >> Share

  178. DURSTENFELD MS, Peluso MJ, Lin F, Peyser ND, et al
    Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study.
    J Med Virol. 2024;96:e29333.
    >> Share

  179. CICCOZZI A, Fiori PL, Casu M, Sanna D, et al
    The mutation point of view of the SARS-CoV-2 HV.1 lineage.
    J Med Virol. 2024;96:e29359.
    >> Share

  180. PONTIROLI AE, Scovenna F, Carlini V, Tagliabue E, et al
    Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID-19: A systematic review and meta-analysis.
    J Med Virol. 2024;96:e29343.
    >> Share

  181. LIANG Z, Tong J, Sun Z, Liu S, et al
    Rational prediction of immunogenicity clustering through cross-reactivity analysis of thirteen SARS-CoV-2 variants.
    J Med Virol. 2024;96:e29314.
    >> Share

  182. HU L, Yang Y, Lin J, Yan Q, et al
    Epidemiological characteristics of respiratory syncytial virus infection in pediatric patients before, during the COVID-19 pandemic and after easing of COVID-19 restrictive measures in China.
    J Med Virol. 2024;96:e29374.
    >> Share

  183. ZHANG Y, Ma Y, Sun W, Zhou X, et al
    Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
    J Med Virol. 2024;96:e29336.
    >> Share

  184. FAVRESSE J, Gillot C, Closset M, Cabo J, et al
    Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster.
    J Med Virol. 2024;96:e29365.
    >> Share

  185. CHOI CY, Gadhave K, Villano J, Pekosz A, et al
    Generation and characterization of a humanized ACE2 mouse model to study long-term impacts of SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29349.
    >> Share

  186. LEE HM, Shih PC, Wei JC
    Comment on Shao et al.'s "Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic".
    J Med Virol. 2024;96:e29383.
    >> Share

  187. LI J, Zhang K, Lin G, Li J, et al
    CRISPR-Cas system: A promising tool for rapid detection of SARS-CoV-2 variants.
    J Med Virol. 2024;96:e29356.
    >> Share

  188. CAPELLI N, Domitien Payet L, Alcocer Cordellat C, Pisoni A, et al
    SARS-CoV-2 nucleocapsid antigen in plasma of children hospitalized for COVID-19 or with incidental detection of SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29358.
    >> Share

  189. CORPECHOT C, Verdoux M, Frank-Soltysiak M, Duclos-Vallee JC, et al
    Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting.
    J Med Virol. 2024;96:e29418.
    >> Share


  190. Corrigendum to "A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus".
    J Med Virol. 2024;96:e29421.
    >> Share

  191. ROMERO-OLMEDO AJ, Schulz AR, Das Gupta D, Staudenraus D, et al
    Unusual T(SCM) -like cells with poly-chemokine-receptor expression in a B-cell-depleted survivor of severe COVID-19.
    J Med Virol. 2024;96:e29367.
    >> Share

  192. HUANG J, Liu Y, Wang J, Xu D, et al
    Pregnancy outcomes after frozen-thawed embryo transfer in women with COVID-19 history: A prospective cohort study.
    J Med Virol. 2024;96:e29377.
    >> Share

  193. LIN WC, Wu MC, Wang YH, Lin CH, et al
    The prevalence of obstructive sleep apnea syndrome after COVID-19 infection.
    J Med Virol. 2024;96:e29392.
    >> Share

  194. SHARMA S, Thiriard A, Olislagers V, Lechien JR, et al
    Mucosal antibody response and SARS-CoV-2 shedding in patients with COVID-19 related olfactory dysfunction.
    J Med Virol. 2024;96:e29398.
    >> Share

  195. VASBINDER A, Padalia K, Pizzo I, Machado K, et al
    SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19.
    J Med Virol. 2024;96:e29389.
    >> Share

  196. HUANG Y, Dong Q, Liu G, Wang T, et al
    A novel three-plasmid packaging system for chimeric SFV/SIN VRPs derived from Semliki Forest virus and Sindbis virus as a candidate gene delivery vector.
    J Med Virol. 2024;96:e29376.
    >> Share

  197. YANG L, Zeng XT, Luo RH, Ren SX, et al
    SARS-CoV-2 NSP12 utilizes various host splicing factors for replication and splicing regulation.
    J Med Virol. 2024;96:e29396.
    >> Share

  198. WANG WT, Chen IW, Hung KC
    Inspiratory muscle training for COVID-19: Benefits appear promising but findings remain uncertain.
    J Med Virol. 2024;96:e29387.
    >> Share

  199. GUO F, Adekanmbi V, Hsu CD, Polychronopoulou E, et al
    One dose versus two doses of COVID-19 vaccine for the prevention of breakthrough infections among people previously infected with SARS-Cov-2.
    J Med Virol. 2024;96:e29391.
    >> Share

  200. ATZLER F, Dahms F, Paul G, Perisic S, et al
    The swab site of the upper airways influences the diagnostic sensitivity for the omicron variant of SARS-CoV-2.
    J Med Virol. 2024;96:e29390.
    >> Share

  201. WANG Y, Lan X, Qiao Y, Huo Y, et al
    Safety and immunogenicity of homologous prime-boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study.
    J Med Virol. 2024;96:e29395.
    >> Share

  202. WANG E, Yang QJ, Xu XX, Zou QC, et al
    Differential pathogenic and molecular features in neurological infection of SARS-CoV-2 Omicron BA.5.2 and BA.2.75 and Delta.
    J Med Virol. 2024;96:e29357.
    >> Share


  203. Correction to "Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19".
    J Med Virol. 2024;96:e29378.
    >> Share

  204. YANG X, Wang Y, Liang Z, Cui T, et al
    Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulations.
    J Med Virol. 2024;96:e29417.
    >> Share

  205. ZHANG T, Magazine N, McGee MC, Carossino M, et al
    Th2 and Th17-associated immunopathology following SARS-CoV-2 breakthrough infection in Spike-vaccinated ACE2-humanized mice.
    J Med Virol. 2024;96:e29408.
    >> Share

  206. JIA J, Garbarino E, Wang Y, Li J, et al
    Generation of SARS-CoV-2 spike receptor binding domain mutants and functional screening for immune evaders using a novel lentivirus-based system.
    J Med Virol. 2024;96:e29425.
    >> Share

  207. SUN Y, Zhou J, Nie W, Tian D, et al
    Study on the epidemiological characteristics of enterovirus among pediatric patients in Hangzhou, China: A comparison between the pre-COVID-19, COVID-19 pandemic, and post-COVID-19 periods.
    J Med Virol. 2024;96:e29412.
    >> Share

    December 2023
  208. HUANG PY, Lai CC, Hsu CK
    Assessing risk factors for COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease.
    J Med Virol. 2023;95:e29281.
    >> Share

  209. LI J, Liu Y, Wei X, Liu Z, et al
    Antibody responses to SARS-CoV-2 Omicron infection in patients with hematological malignancies: A multicenter, prospective cohort study.
    J Med Virol. 2023;95:e29300.
    >> Share

  210. SONG R, Chen X, Li B, Ni J, et al
    Nasal spray of an IgM-like ACE2 fusion protein HH-120 prevents SARS-CoV-2 infection: Two investigator-initiated postexposure prophylaxis trials.
    J Med Virol. 2023;95:e29275.
    >> Share

  211. HORA S, Pahwa P, Siddiqui H, Saxena A, et al
    Metabolic alterations unravel the maternofetal immune responses with disease severity in pregnant women infected with SARS-CoV-2.
    J Med Virol. 2023;95:e29257.
    >> Share

  212. YANG J, Kim HJ, Kim JW, Baek JY, et al
    Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID-19 endemicity.
    J Med Virol. 2023;95:e29285.
    >> Share

  213. GE P, Luo Y, Liu J, Liu J, et al
    Eliminating COVID-19 as the immediate culprit for igniting pancreatitis.
    J Med Virol. 2023;95:e29272.
    >> Share

  214. BAY P, Rodriguez C, Caruso S, Demontant V, et al
    Omicron induced distinct immune respiratory transcriptomics signatures compared to pre-existing variants in critically ill COVID-19 patients.
    J Med Virol. 2023;95:e29268.
    >> Share

  215. YU H, Yang L, Han Z, Zhou X, et al
    SARS-CoV-2 nucleocapsid protein enhances the level of mitochondrial reactive oxygen species.
    J Med Virol. 2023;95:e29270.
    >> Share

  216. TSOI JYH, Cai J, Situ J, Lam WJ, et al
    Autoantibodies against angiotensin-converting enzyme 2 (ACE2) after COVID-19 infection or vaccination.
    J Med Virol. 2023;95:e29313.
    >> Share

  217. MEISTER TL, Kirchhoff L, Bruggemann Y, Todt D, et al
    Stability of pathogens on banknotes and coins: A narrative review.
    J Med Virol. 2023;95:e29312.
    >> Share

  218. CHEN Q, Qin S, Zhou HY, Deng YQ, et al
    Competitive fitness and homologous recombination of SARS-CoV-2 variants of concern.
    J Med Virol. 2023;95:e29278.
    >> Share

  219. YIN ZJ, Xiao H, McDonald S, Brusic V, et al
    Dynamically adjustable SVEIR(MH) model of multiwave epidemics: Estimating the effects of public health measures against COVID-19.
    J Med Virol. 2023;95:e29301.
    >> Share

  220. LI J, Mao H, Song W, Chen Y, et al
    Low neutralization of SARS-CoV-2 Omicron BA.5.2.48, BF.7.14, XBB.1 subvariants by homologous or heterologous booster.
    J Med Virol. 2023;95:e29306.
    >> Share

  221. BENNING L, Bartenschlager M, Kim H, Kalble F, et al
    Live-virus serum neutralization after bivalent SARS-CoV-2 mRNA vaccination in hemodialysis patients.
    J Med Virol. 2023;95:e29303.
    >> Share

  222. FUKUDA Y, Togashi A, Hirakawa S, Yamamoto M, et al
    Resurgence of human metapneumovirus infection and influenza after three seasons of inactivity in the post-COVID-19 era in Hokkaido, Japan, 2022-2023.
    J Med Virol. 2023;95:e29299.
    >> Share

  223. WANG R, Guo J, Lu J, Du P, et al
    A potential broad-spectrum neutralizing antibody against Betacoronavirus.
    J Med Virol. 2023;95:e29252.
    >> Share

  224. XIAO Y, Chang L, Ji H, Sun H, et al
    Posttranslational modifications of ACE2 protein: Implications for SARS-CoV-2 infection and beyond.
    J Med Virol. 2023;95:e29304.
    >> Share

  225. LIU W, Gong F, Zheng X, Pei L, et al
    Factors associated with prolonged viral shedding of SARS-CoV-2 Omicron variant infection in Shanghai: A multicenter, retrospective, observational study.
    J Med Virol. 2023;95:e29342.
    >> Share

  226. LEE DH, Han E, Ryu S, Choi HJ, et al
    Clinical performance of the STANDARD M10 SARS-CoV-2 rapid RT-PCR assay in patients visiting an emergency department.
    J Med Virol. 2023;95:e29330.
    >> Share

  227. KAPUSTA J, Babicki M, Pieniawska-Smiech K, Kaluzinska-Kolat Z, et al
    Clinical and electrocardiographic correlates of myocardial dysfunction after COVID-19 in nonhospitalised patients in long-term follow-up. Data from the polish long-covid cardiovascular study.
    J Med Virol. 2023;95:e29331.
    >> Share

  228. ZHOU Y, Liu Y, Jiang L, Zhang R, et al
    Azvudine and nirmatrelvir-ritonavir in hospitalized patients with moderate-to-severe COVID-19: Emulation of a randomized target trial.
    J Med Virol. 2023;95:e29318.
    >> Share

  229. SULLIVAN DJ, Focosi D, Hanley DF, Cruciani M, et al
    Outpatient randomized controlled trials to reduce COVID-19 hospitalization: Systematic review and meta-analysis.
    J Med Virol. 2023;95:e29310.
    >> Share

  230. LI Y, Yamamoto S, Horii K, Mizoue T, et al
    Long COVID during the Omicron predominant waves among Japanese healthcare workers.
    J Med Virol. 2023;95:e29322.
    >> Share

  231. FEGHOUL L, Caillault A, Peyrony O, Salmona M, et al
    Respiratory torque teno virus load at emergency department visit predicts intensive care unit admission of SARS-CoV-2 infected patients.
    J Med Virol. 2023;95:e29319.
    >> Share

  232. LEE B, Ko JH, Kim YC, Baek JY, et al
    Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants.
    J Med Virol. 2023;95:e29329.
    >> Share

  233. LI J, Nie L, Guo C, Deng Y, et al
    Immunogenicity and safety of inactivated SARS-CoV-2 vaccines in people living with HIV: A longitudinal cohort study.
    J Med Virol. 2023;95:e29334.
    >> Share

    November 2023
  234. LI S, Li X, Liang H, Yu K, et al
    SARS-CoV-2 ORF7a blocked autophagy flux by intervening in the fusion between autophagosome and lysosome to promote viral infection and pathogenesis.
    J Med Virol. 2023;95:e29200.
    >> Share

  235. MAHLA RS
    Interstitial lung diseases and COVID-19 pneumonia.
    J Med Virol. 2023;95:e29207.
    >> Share

  236. KIM IS, Kang CK, Lee SJ, Lee CH, et al
    Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories.
    J Med Virol. 2023;95:e29199.
    >> Share

  237. ZHANG YN, Zhu GH, Liu W, Chen XX, et al
    Discovery of the covalent SARS-CoV-2 M(pro) inhibitors from antiviral herbs via integrating target-based high-throughput screening and chemoproteomic approaches.
    J Med Virol. 2023;95:e29208.
    >> Share

  238. NGIAM JN, Ng OT, Toh MPHS, Gao Q, et al
    Predictors of disease severity in SARS-CoV-2 omicron variant XBB sublineages and variants of interest.
    J Med Virol. 2023;95:e29204.
    >> Share

  239. COLSON P, Bader W, Fantini J, Dudouet P, et al
    From viral democratic genomes to viral wild bunch of quasispecies.
    J Med Virol. 2023;95:e29209.
    >> Share

  240. WANG Y, Wu L, Yu X, Wang G, et al
    Development of a rapid, sensitive detection method for SARS-CoV-2 and influenza virus based on recombinase polymerase amplification combined with CRISPR-Cas12a assay.
    J Med Virol. 2023;95:e29215.
    >> Share

  241. BERGNA A, Lai A, Ventura CD, Bruzzone B, et al
    Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021.
    J Med Virol. 2023;95:e29193.
    >> Share

  242. WANG B, Yang W, Tong Y, Sun M, et al
    Integrative proteomics and metabolomics study reveal enhanced immune responses by COVID-19 vaccine booster shot against Omicron SARS-CoV-2 infection.
    J Med Virol. 2023;95:e29219.
    >> Share

  243. SPRINGER DN, Reuberger E, Borsodi C, Puchhammer-Stockl E, et al
    Comparison of anti-nucleocapsid antibody assays for the detection of SARS-CoV-2 Omicron vaccine breakthroughs after various intervals since the infection.
    J Med Virol. 2023;95:e29229.
    >> Share

  244. KIM Y, Kim Y, Lim HJ, Kim DK, et al
    Integrative single-cell transcriptome analysis provides new insights into post-COVID-19 pulmonary fibrosis and potential therapeutic targets.
    J Med Virol. 2023;95:e29201.
    >> Share

  245. LIU D, Wang Z, Mao M, Zhang Z, et al
    Application of whole-genome tiling array at Shanghai port, China: An alternative method for SARS-CoV-2 surveillance.
    J Med Virol. 2023;95:e29222.
    >> Share

  246. BUCK AM, Deitchman AN, Takahashi S, Lu S, et al
    The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.
    J Med Virol. 2023;95:e29216.
    >> Share

  247. LOW K, Moller R, Stegmann C, Becker M, et al
    Luminescent reporter cells enable the identification of broad-spectrum antivirals against emerging viruses.
    J Med Virol. 2023;95:e29211.
    >> Share

  248. ABDOLAHI T, Maamouri G, Behmadi M, Mirzaeian S, et al
    Investigating the impact of Sinopharm COVID-19 vaccination on antibody response in pregnant women and their newborns.
    J Med Virol. 2023;95:e29231.
    >> Share

  249. RIVAS G, Labiod N, Luczkowiak J, Lasala F, et al
    Superior neutralizing response after first versus second SARS-CoV-2 infection in fully vaccinated individuals.
    J Med Virol. 2023;95:e29225.
    >> Share

  250. WU JY, Liu MY, Hung KC, Hsu WH, et al
    Nutritional deficiency anemia and post-acute sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: A six-month retrospective cohort analysis of 30 892 patients.
    J Med Virol. 2023;95:e29246.
    >> Share

  251. KANG SW, Kim JW, Kim JY, Lim SY, et al
    Virological characteristics and the rapid antigen test as deisolation criteria in immunocompromised patients with COVID-19: A prospective cohort study.
    J Med Virol. 2023;95:e29228.
    >> Share

  252. LI Z, Xiong Y, Long J, Li T, et al
    Resurgence of influenza during COVID-19 in Chongqing, China: A retrospective analysis.
    J Med Virol. 2023;95:e29249.
    >> Share

  253. CHENANE HR, Lingas G, Menidjel R, Laouenan C, et al
    High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients.
    J Med Virol. 2023;95:e29247.
    >> Share

  254. WANG Z, Zhao C, Li C, Liu S, et al
    Molecular PET/CT mapping of rhACE2 distribution and quantification in organs to aid in SARS-CoV-2 targeted therapy.
    J Med Virol. 2023;95:e29221.
    >> Share

  255. HU GM, Tai YC, Chen CM
    Unraveling the evolutionary patterns and phylogenomics of coronaviruses: A consensus network approach.
    J Med Virol. 2023;95:e29233.
    >> Share

  256. MAO R, Fan Z, He M, Li J, et al
    Acne and COVID-19 susceptibility, hospitalization, and severity: A genetic correlation study.
    J Med Virol. 2023;95:e29265.
    >> Share

  257. KONDO Y, Kawamura Y, Hattori F, Nakai H, et al
    Serological analysis of severe acute respiratory syndrome coronavirus 2 infection in children with Kawasaki disease.
    J Med Virol. 2023;95:e29274.
    >> Share

  258. ZENG G, Zhang Z, Wang L, Li J, et al
    Risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients.
    J Med Virol. 2023;95:e29235.
    >> Share

    October 2023
  259. SHIH HL, Lee YT, Sun CK, Chang R, et al
    Considerations regarding the long-term risk of herpes zoster following COVID-19.
    J Med Virol. 2023;95:e29130.
    >> Share

  260. FAPPANI C, Gori M, Bianchi S, Terraneo M, et al
    Differential diagnosis of fever and rash cases negative for measles and rubella to complement surveillance activities.
    J Med Virol. 2023;95:e29141.
    >> Share

  261. XU W, Wen X, Cong X, Jiang W, et al
    COVID-19 mRNA vaccine, but not a viral vector-based vaccine, promotes neutralizing anti-type I interferon autoantibody production in a small group of healthy individuals.
    J Med Virol. 2023;95:e29137.
    >> Share

  262. HOLLSTEIN MM, Dierks S, Schon MP, Bergmann A, et al
    Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-CoV-2 breakthrough infection: Results from the CoV-ADAPT cohort.
    J Med Virol. 2023;95:e29122.
    >> Share

  263. WIEDEL NA, Sayles H, Larson J, Wardian JL, et al
    Associations between COVID-19 therapies and inpatient gastrointestinal bleeding: A multisite retrospective study.
    J Med Virol. 2023;95:e29100.
    >> Share

  264. HU M, Wang X, Li B, Wang B, et al
    Fitness evaluation of SARS-CoV-2 variants: A retrospective study.
    J Med Virol. 2023;95:e29123.
    >> Share

  265. RECTOR A, Bloemen M, Van Ranst M, Wollants E, et al
    Used paper tissues for pathogen identification in acute respiratory infection.
    J Med Virol. 2023;95:e29127.
    >> Share

  266. LI X, Zhang Y, Wang J, Han J, et al
    Long-term dynamic shifts in genomic base content and evolutionary trajectories of SARS-CoV-2 variants.
    J Med Virol. 2023;95:e29128.
    >> Share

  267. LIANG T, Guo K, Ni P, Duan G, et al
    The association of sickle cell disorder with adverse outcomes in COVID-19 patients: A meta-analysis.
    J Med Virol. 2023;95:e29120.
    >> Share

  268. SHI T, Xu L, Li X, Huang L, et al
    The CD19(+) B cell as a marker for the febrile children infected with influenza A and Omicron variant.
    J Med Virol. 2023;95:e29097.
    >> Share

  269. FENG S, Fan Z, Zhou K, Ma S, et al
    Subunit vaccine raised against the SARS-CoV-2 spike of Delta and Omicron variants.
    J Med Virol. 2023;95:e29160.
    >> Share

  270. LIU J, Zhang H, Kong J, Liu S, et al
    Alleviated symptoms of SARS-CoV-2 Omicron variant infection in chronic hepatitis B patients with immune control.
    J Med Virol. 2023;95:e29173.
    >> Share

  271. BREZNIK JA, Rahim A, Bhakta H, Clare R, et al
    Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort study.
    J Med Virol. 2023;95:e29170.
    >> Share

  272. GAO Y, Zhang Y, Mou K, Liu Y, et al
    Assessment of alterations in the retina and vitreous in pre- and post-COVID-19 patients using swept-source optical coherence tomography and angiography: A comparative study.
    J Med Virol. 2023;95:e29168.
    >> Share

  273. YI J, Li X, Zhang R, Kong L, et al
    The impact of the COVID-19 pandemic on the prevalence and genotype distribution of HPV infection in Beijing, China.
    J Med Virol. 2023;95:e29155.
    >> Share

  274. BA Z, Yang A, Zhu S, Li Y, et al
    Comprehensive evaluation of the effect of inactivated SARS-CoV-2 vaccination on female fertility: A retrospective cohort study.
    J Med Virol. 2023;95:e29161.
    >> Share

  275. HU Z, Jin Z, Zhou M, Zhang C, et al
    CoronaVac and BBIBP-CorV vaccines against SARS-CoV-2 during predominant circulation of Omicron BA.5.2 and BF.7 in China, a retrospective cohort study.
    J Med Virol. 2023;95:e29143.
    >> Share

  276. ABBASI HQ
    Comments on: Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome.
    J Med Virol. 2023;95:e29167.
    >> Share

  277. MATIC S, Milovanovic D, Mijailovic Z, Djurdjevic P, et al
    Its all about IFN-lambda4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females.
    J Med Virol. 2023;95:e29152.
    >> Share

  278. COLSON P, La Scola B, Beye M, Delerce J, et al
    Emergence of a second SARS-CoV-2 variant with a tremendous genetic leap from its ancestors.
    J Med Virol. 2023;95:e29124.
    >> Share

  279. WEI D, Yu X, Li Y, Chen Y, et al
    Sequential reinfection with Omicron variants elicits broader neutralizing antibody profiles in booster vaccinees and reduces the duration of viral shedding.
    J Med Virol. 2023;95:e29151.
    >> Share

  280. CHEN D, Li X, Hao X, Qiu Y, et al
    Reduced neutralization and Fc effector function to Omicron subvariants in sera from SARS-CoV-1 survivors after two doses of CoronaVac plus one dose subunit vaccine.
    J Med Virol. 2023;95:e29136.
    >> Share

  281. JIAO F, Andrianov AM, Wang L, Furs KV, et al
    Repurposing Navitoclax to block SARS-CoV-2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein.
    J Med Virol. 2023;95:e29145.
    >> Share

  282. YANG X, Hu C, Yang X, Yang X, et al
    Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice.
    J Med Virol. 2023;95:e29140.
    >> Share

  283. LIU S, Wang P, Shi X, Weng T, et al
    Maternal antibody transfer rate of vaccination against SARS-CoV-2 before or during early pregnancy and its protective effectiveness on offspring.
    J Med Virol. 2023;95:e29125.
    >> Share

  284. COLSON P, Delerce J, Fantini J, Pontarotti P, et al
    The return of the "Mistigri" (virus adaptative gain by gene loss) through the SARS-CoV-2 XBB.1.5 chimera that predominated in 2023.
    J Med Virol. 2023;95:e29146.
    >> Share

  285. DE FRANCESCO MA, Piva S, Pellizzeri S, Signorini L, et al
    Response to the Letter to the Editor on "Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS-CoV-2 infection than negative patients and are associated to a worse outcome".
    J Med Virol. 2023;95:e29192.
    >> Share

  286. WANG Q, Jia M, Jiang M, Cao Y, et al
    Increased population susceptibility to seasonal influenza during the COVID-19 pandemic in China and the United States.
    J Med Virol. 2023;95:e29186.
    >> Share

  287. MOHAMMADI-PILEHDARBONI H, Shenagari M
    Regarding the article Causal effect of COVID-19 on Alzheimer's disease: A Mendelian randomization study by Baranova et al.
    J Med Virol. 2023;95:e29176.
    >> Share

  288. CACCURI F, Messali S, Scarpa F, Giovanetti M, et al
    First detection of SARS-CoV-2 BA.2.86.1 in Italy.
    J Med Virol. 2023;95:e29175.
    >> Share

  289. LI T, Chen N, Wang X, Chen N, et al
    Epidemiology of influenza A outbreak among children after COVID-19: A single-center retrospective observational study.
    J Med Virol. 2023;95:e29174.
    >> Share

  290. AHN H, Calderon BM, Fan X, Gao Y, et al
    Structural basis of the American mink ACE2 binding by Y453F trimeric spike glycoproteins of SARS-CoV-2.
    J Med Virol. 2023;95:e29163.
    >> Share

  291. MEYERS E, Park J, Coen A, Raman L, et al
    Evaluation of a smartphone-operated point-of-care device using loop-mediated isothermal amplification technology for rapid and remote detection of SARS-CoV-2.
    J Med Virol. 2023;95:e29158.
    >> Share

  292. BASTOS V, Pacheco V, Rodrigues EDL, Moraes CNS, et al
    Neuroimmunology of rabies: New insights into an ancient disease.
    J Med Virol. 2023;95:e29042.
    >> Share

  293. HSIA NY, Hsu AY, Wang YH, Li JX, et al
    The risk assessment of uveitis after COVID-19 diagnosis: A multicenter population-based study.
    J Med Virol. 2023;95:e29188.
    >> Share

  294. QI Z, Yuan S, Wei J, Xia S, et al
    Clinical and pathological features of omicron variant of SARS-CoV-2-associated kidney injury.
    J Med Virol. 2023;95:e29196.
    >> Share

  295. ARONS E, Henry K, Haas C, Gould M, et al
    Characterization of B-cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS-CoV-2 infection.
    J Med Virol. 2023;95:e29179.
    >> Share

    September 2023

  296. Correction to "Safety and immunogenicity of COVID-19 vaccination in patients with hepatocellular carcinoma (CHESS-NMCID 2101): A multicenter prospective study".
    J Med Virol. 2023;95:e29063.
    >> Share

  297. SENGUPTA S, Shaw SK, Chatterjee S, Bhattacharya G, et al
    Perturbations in spike-specific peripheral T follicular helper cells in SARS-CoV2 breakthrough convalescent individuals immunized by BBV152 vaccine.
    J Med Virol. 2023;95:e29053.
    >> Share

  298. ZHOU H, Xie P, Qiu M, Dong S, et al
    Arbidol increases the survival rate by mitigating inflammation in suckling mice infected with human coronavirus OC43 virus.
    J Med Virol. 2023;95:e29052.
    >> Share

  299. DAS S, Kumar S
    Exploring the mechanisms of long COVID: Insights from computational analysis of SARS-CoV-2 gene expression and symptom associations.
    J Med Virol. 2023;95:e29077.
    >> Share

  300. AHLUWALIA P, Vashisht A, Singh H, Sahajpal NS, et al
    Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers.
    J Med Virol. 2023;95:e29067.
    >> Share

  301. MA J, Qiu S
    Infection with critically ill COVID-19 increases the risk of cardioembolic stroke.
    J Med Virol. 2023;95:e29066.
    >> Share

  302. MOLINA IS, Jimenez-Vasquez V, Lizarraga W, Sevilla N, et al
    Sub-lineage B.1.6 of hMPXV in a global context: Phylogeny and epidemiology.
    J Med Virol. 2023;95:e29056.
    >> Share

  303. CASO JM, Fernandez-Ruiz M, Lopez-Medrano F, Caro-Teller JM, et al
    Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience.
    J Med Virol. 2023;95:e29082.
    >> Share

  304. HAO S, Ning K, Kuz CA, Xiong M, et al
    SARS-CoV-2 infection of polarized human airway epithelium induces necroptosis that causes airway epithelial barrier dysfunction.
    J Med Virol. 2023;95:e29076.
    >> Share

  305. SCARPA F, Ciccozzi M
    On the SARS-CoV-2 BA.2.86 lineage: a mutation point of view.
    J Med Virol. 2023;95:e29079.
    >> Share

  306. SCARPA F, Pascarella S, Ciccozzi A, Giovanetti M, et al
    Genetic and structural analyses reveal the low potential of the SARS-CoV-2 EG.5 variant.
    J Med Virol. 2023;95:e29075.
    >> Share

  307. SHAO C, Shi Y, Chen R, Liu X, et al
    Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic.
    J Med Virol. 2023;95:e29098.
    >> Share

  308. HOSSAIN MS, Kerkvliet JG, Hoppe AD
    Whole genome CRISPR screening strategy to identify genes contributing to SARS-CoV-2 spike and VSV-G mediated entry.
    J Med Virol. 2023;95:e29087.
    >> Share

  309. ZHANG B, Tsai YW, Wu JY, Liu TH, et al
    Risk of cytomegalovirus diseases among coronavirus disease survivors: A retrospective cohort study.
    J Med Virol. 2023;95:e29096.
    >> Share

  310. TSO WW, Kwan MY, Ip P, Chan JF, et al
    Response to the Letter to the Editor on "Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection".
    J Med Virol. 2023;95:e29095.
    >> Share

  311. HUANG SW, Yeh WB, Chen HY, Yong SB, et al
    Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients.
    J Med Virol. 2023;95:e29101.
    >> Share

  312. HANSEN KS, Jorgensen SE, Skouboe MK, Agergaard J, et al
    Examination of autoantibodies to type I interferon in patients suffering from long COVID.
    J Med Virol. 2023;95:e29089.
    >> Share

  313. ZUO T, Liang G, Huang Z, Cao Z, et al
    Baseline gut microbiome features prior to SARS-CoV-2 infection are associated with host symptoms in and post COVID-19.
    J Med Virol. 2023;95:e29083.
    >> Share

  314. CAKIR C, Kuspinar G, Kurt G, Berber M, et al
    Comparison of semen parameters in the same patients before and after diagnosis of COVID-19.
    J Med Virol. 2023;95:e29094.
    >> Share

  315. CHU WM, Hsieh TH, Wei JC
    Comment on Tsai et al.'s "clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data".
    J Med Virol. 2023;95:e29086.
    >> Share

  316. JIANG T, Liu R, Shen J
    CRISPR dual enzyme cleavage triggers DNA and RNA substrate cleavage for SARS-CoV-2 dual gene detection.
    J Med Virol. 2023;95:e29090.
    >> Share

  317. RAFATI A, Jameie M, Amanollahi M, Jameie M, et al
    Association of seizure with COVID-19 vaccines in persons with epilepsy: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e29118.
    >> Share

  318. YULUG B, Ayyildiz B, Ayyildiz S, Sayman D, et al
    Infection with COVID-19 is no longer a public emergency: But what about degenerative dementia?
    J Med Virol. 2023;95:e29072.
    >> Share

  319. DE SOUSA LAF, Ferreira LSS, Lobato LFL, Ferreira HLDS, et al
    Molecular epidemiology of SARS-CoV-2 variants in circulation in the state of Maranhao, Brazil.
    J Med Virol. 2023;95:e29092.
    >> Share

  320. XIANG Y, Mou C, Shi K, Chen X, et al
    SADS-CoV nsp1 inhibits the IFN-beta production by preventing TBK1 phosphorylation and inducing CBP degradation.
    J Med Virol. 2023;95:e29104.
    >> Share

  321. TSAI YW, Wu JY, Liu TH, Chuang MH, et al
    Clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data.
    J Med Virol. 2023;95:e29085.
    >> Share

  322. BRUZZESI E, Gabrieli A, Bernasconi D, Marchetti G, et al
    HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial.
    J Med Virol. 2023;95:e29114.
    >> Share

  323. ZHAN Y, Ye L, Ouyang Q, Yin J, et al
    The binding profile of SARS-CoV-2 with human leukocyte antigen polymorphisms reveals critical alleles involved in immune evasion.
    J Med Virol. 2023;95:e29113.
    >> Share

  324. LI B, Zhang J, Huang Y, Li X, et al
    A conserved N protein nano-vaccine of COVID-19 exerts potent and cross-reactive humoral and cellular immune responses in mice.
    J Med Virol. 2023;95:e29115.
    >> Share

  325. COELHO GM, Cataneo AHD, Raboni SM, Nogueira MB, et al
    Development of an anti-SARS-CoV-2 monoclonal antibody panel and its applicability as a reagent in high-throughput fluorescence reduction neutralization and immunohistochemistry assays.
    J Med Virol. 2023;95:e29111.
    >> Share

    August 2023
  326. ROY A, Saade C, Josset L, Clement B, et al
    Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients.
    J Med Virol. 2023;95:e28984.
    >> Share

  327. CHEN Y, Liu X, Tong Z
    Can inspiratory muscle training benefit patients with COVID-19? A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28956.
    >> Share

  328. ZENG G, Li J, Wang L, Zhang Z, et al
    Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital.
    J Med Virol. 2023;95:e28988.
    >> Share

  329. YU W, Guo Y, Hu T, Liu Y, et al
    Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China.
    J Med Virol. 2023;95:e28997.
    >> Share

  330. LI X, Chen N, Wang X, Li T, et al
    Epidemiology of respiratory syncytial virus outbreak among children after the COVID-19 pandemic.
    J Med Virol. 2023;95:e29017.
    >> Share

  331. HIRATA Y, Katano H, Iida S, Mine S, et al
    Genomic analysis of SARS-CoV-2 in forensic autopsy cases of COVID-19.
    J Med Virol. 2023;95:e28990.
    >> Share

  332. VELAZQUEZ-SALINAS L
    Deciphering the evolutionary mechanisms of SARS-CoV-2: Absence of ORF8 protein and its potential advantage in the emergence of viral lineages.
    J Med Virol. 2023;95:e29002.
    >> Share

  333. ZUIN M, Mazzitelli M, Cattelan A
    Long-COVID: Is it time to revise the definition?
    J Med Virol. 2023;95:e29011.
    >> Share

  334. LIU TH, Chuang MH, Wu JY, Huang PY, et al
    Effectiveness of oral antiviral agents on long-term cardiovascular risk in nonhospitalized patients with COVID-19: A multicenter matched cohort study.
    J Med Virol. 2023;95:e28992.
    >> Share

  335. SHANG S, Fu B, Geng Y, Zhang J, et al
    Azvudine therapy of common COVID-19 in hemodialysis patients.
    J Med Virol. 2023;95:e29007.
    >> Share

  336. WANG Y, Zhao D, Xiao W, Shi J, et al
    Paxlovid reduces the risk of Long COVID in patients six months after hospital discharge.
    J Med Virol. 2023;95:e29014.
    >> Share

  337. ZHIYANOV A, Shkurnikov M, Nersisyan A, Hui C, et al
    The signature of SARS-CoV-2 evolution reflects selective pressures within human guts.
    J Med Virol. 2023;95:e28996.
    >> Share

  338. ABBASI HQ
    Comments on: Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection.
    J Med Virol. 2023;95:e29008.
    >> Share

  339. MOHAMMADI B, Dua K, Saghafi M, Singh SK, et al
    COVID-19-induced autoimmune thyroiditis: Exploring molecular mechanisms.
    J Med Virol. 2023;95:e29001.
    >> Share

  340. WASSERMAN EB, Sills AK, Martins D, Casolaro A, et al
    Factors associated with antibody titer levels among an occupational cohort of fully vaccinated individuals and subsequent risk of COVID-19 infection: A cohort study.
    J Med Virol. 2023;95:e28999.
    >> Share

  341. THURLAPATI A, McGann M, Davis JA, Granger K, et al
    Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients.
    J Med Virol. 2023;95:e29027.
    >> Share

  342. BAI Y, Shen L, Sun M, Yang Z, et al
    The short and long-term impact of nonpharmaceutical interventions on the prevalence of varicella in Xi'an during the COVID-19 pandemic.
    J Med Virol. 2023;95:e29020.
    >> Share

  343. LIU M, Zhang J, Li L, Tian J, et al
    Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescents.
    J Med Virol. 2023;95:e28998.
    >> Share

  344. GIOVANETTI M, Branda F, Cella E, Scarpa F, et al
    Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2.
    J Med Virol. 2023;95:e29012.
    >> Share

  345. HOQUE SA, Pham NTK, Onda-Shimizu Y, Nishimura S, et al
    Sapovirus infections in Japan before and after the emergence of the COVID-19 pandemic: An alarming update.
    J Med Virol. 2023;95:e29023.
    >> Share

  346. ISHISAKA Y, Aikawa T, Malik A, Kampaktsis PN, et al
    Association of Remdesivir use with bradycardia: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e29018.
    >> Share

  347. SUN Z, Wang S, Sun X, Shi Y, et al
    COVID-19 has causal effects on cancer risk? Something we might ignore.
    J Med Virol. 2023;95:e29034.
    >> Share

  348. BAUER C, Mack E, Hefter V, Fischer A, et al
    Impaired systemic nucleocapsid antigen clearance in severe COVID-19.
    J Med Virol. 2023;95:e29032.
    >> Share

  349. MAK WA, Visser W, van der Vliet M, Markus HY, et al
    Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals.
    J Med Virol. 2023;95:e28989.
    >> Share

  350. DAS A, Meng W, Liu Z, Hasib MM, et al
    Molecular and immune signatures, and pathological trajectories of fatal COVID-19 lungs defined by in situ spatial single-cell transcriptome analysis.
    J Med Virol. 2023;95:e29009.
    >> Share

  351. LU S, Luo S, Bai B, Fan Z, et al
    Omicron breakthrough infections in wild-type SARS-CoV-2 vaccinees elicit high levels of neutralizing antibodies against pangolin coronavirus GX_P2V.
    J Med Virol. 2023;95:e29031.
    >> Share

  352. FANG C, Yan W, Chen Y, Dou Z, et al
    Long-term SARS-CoV-2 neutralizing antibody level prediction using multimodal deep learning: A prospective cohort study on longitudinal data in Wuhan, China.
    J Med Virol. 2023;95:e29036.
    >> Share

  353. FOURIE E, Bording ES, Euser SM, Badoux P, et al
    Nasal discharge: A unique enhanced alternative for the detection of respiratory pathogens in adults.
    J Med Virol. 2023;95:e29047.
    >> Share

  354. ZHAO Y, Zhao Y, Zhu J, Lei L, et al
    Association of inactivated COVID-19 vaccination with maternal coagulation function in early pregnancy.
    J Med Virol. 2023;95:e29051.
    >> Share

  355. GUO H, Yin M, Liu Y, Wang B, et al
    COVID-19 infection after oocyte retrieval did not have detrimental effects on embryo implantation for frozen embryo transfer.
    J Med Virol. 2023;95:e29054.
    >> Share

  356. BASTO-ABREU A, Carnalla M, Torres-Ibarra L, Sanchez-Pajaro A, et al
    SARS-CoV-2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico.
    J Med Virol. 2023;95:e29038.
    >> Share

  357. ZHAO Y, Zhang H, Zhao Z, Liu F, et al
    Efficacy and safety of Oral LL-37 against the Omicron BA.5.1.3 variant of SARS-COV-2: A randomized trial.
    J Med Virol. 2023;95:e29035.
    >> Share

  358. GONDIM RNDG, de Arruda EAG, Neto RDJP, Medeiros MS, et al
    Cytokines, chemokines, and cells growth factors in patients with mild to moderate SARS-CoV-2 infection: A case-control study.
    J Med Virol. 2023;95:e29044.
    >> Share

  359. NGUYEN NN, Houhamdi L, Meddeb L, Colson P, et al
    Reinfection with SARS-CoV-2 Omicron BA.4 and BA.5 variants.
    J Med Virol. 2023;95:e29033.
    >> Share

  360. SILVA MFS, de Oliveira FCE, Pinto ACMD, Luciano MCDS, et al
    Antibody response following the fourth SARS-CoV-2 vaccine dose during the Omicron wave in Brazil.
    J Med Virol. 2023;95:e29055.
    >> Share

  361. GUTERRES A
    Viral load: We need a new look at an old problem?
    J Med Virol. 2023;95:e29061.
    >> Share

  362. YANG H, Wang Z, Zhang Y, Xu M, et al
    Clinical characteristics and factors for serious outcomes among outpatients infected with the Omicron subvariant BF.7.
    J Med Virol. 2023;95:e28977.
    >> Share

  363. LIAO HC, Huang MS, Chiu FF, Chai KM, et al
    Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2.
    J Med Virol. 2023;95:e29040.
    >> Share

    July 2023
  364. SOLIS M, Benotmane I, Gallais F, Caillard S, et al
    Torque teno virus viral load predicts SARS-CoV-2 vaccine response in kidney transplant recipients.
    J Med Virol. 2023;95:e28936.
    >> Share

  365. ZHAO Q, Wang X, Zhang Z, Liu X, et al
    Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld.
    J Med Virol. 2023;95:e28932.
    >> Share

  366. KHAN M, Khan K, Motwani J
    Comment on "Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients".
    J Med Virol. 2023;95:e28938.
    >> Share

  367. TSO WW, Kwan MY, Kwok JS, Tsang JO, et al
    Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection.
    J Med Virol. 2023;95:e28895.
    >> Share

  368. GATES S, Andreani J, Dewar R, Smith DB, et al
    Postpandemic rebound of adeno-associated virus type 2 (AAV2) infections temporally associated with an outbreak of unexplained severe acute hepatitis in children in the United Kingdom.
    J Med Virol. 2023;95:e28921.
    >> Share

  369. ALBERT E, Fernandez-Soto D, Gimenez E, Casanovas JM, et al
    Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naive individuals.
    J Med Virol. 2023;95:e28900.
    >> Share

  370. HUANG PY, Liu TH, Wu JY, Tsai YW, et al
    Response to the letter to the editor on "Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials".
    J Med Virol. 2023;95:e28918.
    >> Share

  371. YI S, Zhang SS, Wang XR, Zhou Y, et al
    Dynamics of parainfluenza virus among hospitalized children with acute respiratory tract infection under two-child policy and COVID-19 pandemic in Hubei Province, China, 2014-2022.
    J Med Virol. 2023;95:e28899.
    >> Share

  372. ZHANG H, Lu Z, Yang F, Chen H, et al
    Symptom profiles and vaccination status for COVID-19 after the adjustment of the dynamic zero-COVID policy in China: An observational study.
    J Med Virol. 2023;95:e28893.
    >> Share

  373. RAMUNNO M, Savitz R
    COVID-19 vaccination and decreased death rates: A county-level study in Pennsylvania.
    J Med Virol. 2023;95:e28883.
    >> Share

  374. DE FRANCESCO MA, Signorini L, Piva S, Pellizzeri S, et al
    Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome.
    J Med Virol. 2023;95:e28892.
    >> Share

  375. RAHMATI M, Yon DK, Lee SW, Soysal P, et al
    New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28909.
    >> Share

  376. MIELKE A, Denwood M, Christiansen LE
    Estimating true prevalence through questionnaire data.
    J Med Virol. 2023;95:e28908.
    >> Share

  377. CHUNG HY, Jian MJ, Chang CK, Lin JC, et al
    Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking.
    J Med Virol. 2023;95:e28914.
    >> Share

  378. GUO Z, Jin Q, Li P, Xing G, et al
    Potential cross-species transmission risks of emerging swine enteric coronavirus to human beings.
    J Med Virol. 2023;95:e28919.
    >> Share

  379. SENDI P, Widmer N, Branca M, Thierstein M, et al
    Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohort.
    J Med Virol. 2023;95:e28904.
    >> Share

  380. KANG SY, Yoo JR, Park Y, Kim SH, et al
    Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID-19 is associated with the hyperproduction of IL-10 and IL-6 and the low production of TGF-beta.
    J Med Virol. 2023;95:e28894.
    >> Share

  381. LIN WC, Wei JC
    Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients.
    J Med Virol. 2023;95:e28903.
    >> Share

  382. LIU TH, Wu JY, Huang PY, Tsai YW, et al
    The effect of nirmatrelvir-ritonavir on the long-term risk of neuropsychiatric sequelae following COVID-19.
    J Med Virol. 2023;95:e28951.
    >> Share

  383. AN Y, Zhao G, Duan H, Zhang N, et al
    Robust and protective immune responses induced by heterologous prime-boost vaccination with DNA-protein dimeric RBD vaccines for COVID-19.
    J Med Virol. 2023;95:e28948.
    >> Share

  384. MA Q, Xu G
    New-onset and relapsed thrombotic microangiopathy post-COVID-19 vaccination.
    J Med Virol. 2023;95:e28946.
    >> Share

  385. GHAZIZADEH ESSLAMI G, Mamishi S, Pourakbari B, Mahmoudi S, et al
    Systematic review and meta-analysis on the serological, immunological, and cardiac parameters of the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection.
    J Med Virol. 2023;95:e28927.
    >> Share

  386. CHEN YC, Ho CH, Liu TH, Wu JY, et al
    Response to the letter to the editor on "Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients".
    J Med Virol. 2023;95:e28945.
    >> Share

  387. HUANG Y, Zhu X, Guo X, Zhou Y, et al
    Advances in mRNA vaccines for viral diseases.
    J Med Virol. 2023;95:e28924.
    >> Share

  388. HUANG C
    Comment on Huang PS et al. Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials. Med Virol. 2023; 95: e28621.
    J Med Virol. 2023;95:e28907.
    >> Share

  389. CHEN H, Ye B, Su W, Song Y, et al
    The causal role of gut microbiota in susceptibility and severity of COVID-19: A bidirectional Mendelian randomization study.
    J Med Virol. 2023;95:e28880.
    >> Share

  390. KOZAWA K, Kawamura Y, Hattori F, Miura H, et al
    Changes in trends of pediatric beta- and gamma-herpesvirus infections during the COVID-19 pandemic: A single-center observational study.
    J Med Virol. 2023;95:e28925.
    >> Share

  391. KIRSCH JA, Slutske WS, McCarthy DE, Smith SS, et al
    Factors associated with 60-day readmission among inpatients with COVID-19 at 21 United States health systems.
    J Med Virol. 2023;95:e28972.
    >> Share

  392. YANG H, Wang Z, Jiang C, Zhang Y, et al
    Oral azvudine for mild-to-moderate COVID-19 in high risk, nonhospitalized adults: Results of a real-world study.
    J Med Virol. 2023;95:e28947.
    >> Share

  393. PONIEDZIALEK B, Rzymski P, Zarebska-Michaluk D, Rogalska M, et al
    Short-term exposure to ambient air pollution and COVID-19 severity during SARS-CoV-2 Delta and Omicron waves: A multicenter study.
    J Med Virol. 2023;95:e28962.
    >> Share

  394. KIM Y, Kim S, Kim HJ, Kwon R, et al
    National trends in body mass index, overweight, and obesity among adults before and during the COVID-19 pandemic in 2009-2021: A representative longitudinal serial study in South Korea.
    J Med Virol. 2023;95:e28958.
    >> Share

  395. FANG Q, He X, Zheng X, Fu Y, et al
    Verifying AXL and putative proteins as SARS-CoV-2 receptors by DnaE intein-based rapid cell-cell fusion assay.
    J Med Virol. 2023;95:e28953.
    >> Share


  396. Retraction: Zhang, N, Qi, X, Chang, H, et al. Combined effects of inflammation and coronavirus disease 2019 (COVID-19) on the risks of anxiety and depression: a cross-sectional study based on UK Biobank. J Med Virol. 2023; 95:e28726. doi:10.1002/jmv.2
    J Med Virol. 2023;95:e28937.
    >> Share

  397. HE J, Mei Q, Peng Y, Xie J, et al
    Are the original SARS-CoV-2 novel mutants from in vitro culture able to escape the immune response?
    J Med Virol. 2023;95:e28931.
    >> Share


  398. Correction to "Long-Term Risk of Herpes Zoster Following Covid-19: A Retrospective Cohort Study of 2 442 686 Patients".
    J Med Virol. 2023;95:e28944.
    >> Share

  399. QU Y, Wang W, Xiao MZX, Zheng Y, et al
    The interplay between lipid droplets and virus infection.
    J Med Virol. 2023;95:e28967.
    >> Share


  400. Correction to "Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: a systematic review and meta-analysis of randomized control trials".
    J Med Virol. 2023;95:e28916.
    >> Share


  401. Correction to "SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2".
    J Med Virol. 2023;95:e28935.
    >> Share

  402. AUGUSTINE G, Sisila V, Indhu M, Gupta D, et al
    Redirecting the JAK-STAT signal blocks the SARS-CoV-2 replication.
    J Med Virol. 2023;95:e28965.
    >> Share

  403. VISOS-VARELA I, Zapata-Cachafeiro M, Pintos-Rodriguez S, Bugarin-Gonzalez R, et al
    Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study.
    J Med Virol. 2023;95:e28971.
    >> Share

  404. SHARIQ M, Malik AA, Sheikh JA, Hasnain SE, et al
    Regulation of autophagy by SARS-CoV-2: The multifunctional contributions of ORF3a.
    J Med Virol. 2023;95:e28959.
    >> Share

  405. WATANABE A, Malik A, Aikawa T, Briasoulis A, et al
    Extracorporeal membrane oxygenation for COVID-19-associated acute respiratory distress syndrome: A nationwide analysis.
    J Med Virol. 2023;95:e28961.
    >> Share

    June 2023
  406. LIN YY, Yao R, Zhuang J, Wang B, et al
    PACT inhibits the replication of SARS-CoV-2 through the blockage of GSK-3beta-N-nsp3 cascade.
    J Med Virol. 2023;95:e28832.
    >> Share

  407. RAHMATI M, Yon DK, Lee SW, Udeh R, et al
    New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies.
    J Med Virol. 2023;95:e28833.
    >> Share

  408. QIAN X, Wu B, Chen X, Peng H, et al
    Multi-omic and comparative analyses revealed monocyte-derived alpha-defensin-1 correlated with COVID-19 severity and inhibited SARS-CoV-2 infection.
    J Med Virol. 2023;95:e28845.
    >> Share

  409. REN Y, Wang G, Han D
    Statins in hospitalized COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    J Med Virol. 2023;95:e28823.
    >> Share

  410. GUO M, Zhu J, Hu Z, Wang Q, et al
    Histone mRNA polyadenylation-mediated inflammation underlies various virus infections and cancers.
    J Med Virol. 2023;95:e28826.
    >> Share

  411. ZENG G, Wang L, Li J, Zhang Z, et al
    Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19.
    J Med Virol. 2023;95:e28836.
    >> Share

  412. BOSKOVIC B, Bilic I, Soda J, Kero I, et al
    Transcranial magnetic stimulation in assessment of vocal cord paralysis due to post-viral (COVID-19) vagal neuropathy.
    J Med Virol. 2023;95:e28838.
    >> Share

  413. MONDI A, Mastrorosa I, Piselli P, Cimaglia C, et al
    Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.
    J Med Virol. 2023;95:e28831.
    >> Share

  414. GAULT N, Bachelet D, Laouenan C, Borie R, et al
    Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study.
    J Med Virol. 2023;95:e28819.
    >> Share

  415. MESSALI S, Rondina A, Giovanetti M, Bonfanti C, et al
    Traceability of SARS-CoV-2 transmission through quasispecies analysis.
    J Med Virol. 2023;95:e28848.
    >> Share

  416. RAHMATI M, Udeh R, Yon DK, Lee SW, et al
    A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences.
    J Med Virol. 2023;95:e28852.
    >> Share

  417. RANARD BL, Chow CC, Megjhani M, Asgari S, et al
    A mathematical model of SARS-CoV-2 immunity predicts paxlovid rebound.
    J Med Virol. 2023;95:e28854.
    >> Share

  418. REDLBERGER-FRITZ M, Springer DN, Aberle SW, Camp JV, et al
    Respiratory syncytial virus surge in 2022 caused by lineages already present before the COVID-19 pandemic.
    J Med Virol. 2023;95:e28830.
    >> Share

  419. YU W, Wang J, Yang Y, Tang C, et al
    SARS-CoV-2 Omicron (B.1.1.529) infection in rhesus macaques, hamsters, and BALB/c mice with severe lung histopathological damage.
    J Med Virol. 2023;95:e28846.
    >> Share

  420. OH T, Kim G, Baek SH, Woo Y, et al
    Comparative spatial transcriptomic profiling of severe acute respiratory syndrome coronavirus 2 Delta and Omicron variants infections in the lungs of cynomolgus macaques.
    J Med Virol. 2023;95:e28847.
    >> Share

  421. LI J, Wang B, He X, Li Z, et al
    Epidemiological characteristics of norovirus infection in pediatric patients during the COVID-19 pandemic.
    J Med Virol. 2023;95:e28874.
    >> Share

  422. TSAI YW, Wu JY, Liu TH, Chuang MH, et al
    Clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data.
    J Med Virol. 2023;95:e28869.
    >> Share

  423. WU JY, Liu MY, Liu TH, Chuang MH, et al
    Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID-19.
    J Med Virol. 2023;95:e28866.
    >> Share

  424. FENG K, Zhang HJ, Min YQ, Zhou M, et al
    SARS-CoV-2 NSP13 interacts with host IRF3, blocking antiviral immune responses.
    J Med Virol. 2023;95:e28881.
    >> Share

  425. PEREZ-CATALAN I, Gomez-Alfaro I, Garcia-Munoz S, Roig-Marti C, et al
    Antiviral treatment or mAbs for persistent SARS-COV-2 infection in patients with hematologic malignancies: A case series.
    J Med Virol. 2023;95:e28865.
    >> Share

  426. LI F, Xu K, Pan Y, Liu P, et al
    Stability of SARS-CoV-2 and persistence of viral nucleic acids on common foods and widely used packaging material surfaces.
    J Med Virol. 2023;95:e28871.
    >> Share

  427. YE RZ, Gong C, Cui XM, Liu JY, et al
    Continuous evolution and emerging lineage of seasonal human coronaviruses: A multicenter surveillance study.
    J Med Virol. 2023;95:e28861.
    >> Share

  428. DOBROWOLSKA K, Zarebska-Michaluk D, Poniedzialek B, Jaroszewicz J, et al
    Overview of autoantibodies in COVID-19 convalescents.
    J Med Virol. 2023;95:e28864.
    >> Share

  429. KO M, Lee JY, Shin YS, Jeon S, et al
    Novel SARS-CoV-2 entry inhibitors, 2-anilinoquinazolin-4(3H)-one derivatives, show potency as SARS-CoV-2 antivirals in a human ACE2 transgenic mouse model.
    J Med Virol. 2023;95:e28863.
    >> Share

  430. CROOKS CJ, West J, Gazis T, Simmonds M, et al
    Maximal temperature varies by sex and ethnic group in hospital in-patients with Covid-19 infection.
    J Med Virol. 2023;95:e28837.
    >> Share

  431. VASCONCELOS MW, de Barros FRO, Pilonetto JC, Rosa SGB, et al
    Relationship between SARS-CoV-2 vaccination and cases, program breakthrough cases, and deaths in Dois Vizinhos, Parana, Brazil.
    J Med Virol. 2023;95:e28882.
    >> Share

  432. WATANABE Y, Yamamoto H, Matsuba I, Watanabe K, et al
    Time-series transcriptome analysis of peripheral blood mononuclear cells obtained from individuals who received the SARS-CoV-2 mRNA vaccine.
    J Med Virol. 2023;95:e28884.
    >> Share

  433. AHMADI AS, Zadheidar S, Sadeghi K, Nejati A, et al
    SARS-CoV-2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment.
    J Med Virol. 2023;95:e28877.
    >> Share

  434. RAMJATTUN K, Ma X, Gao SJ, Singh H, et al
    COVID-19db linkage maps of cell surface proteins and transcription factors in immune cells.
    J Med Virol. 2023;95:e28887.
    >> Share

  435. CAO G, Guo Z, Liu J, Liu M, et al
    Change from low to out-of-season epidemics of influenza in China during the COVID-19 pandemic: A time series study.
    J Med Virol. 2023;95:e28888.
    >> Share

  436. XIE Y, Yang M, Zhou P, Fan J, et al
    New-onset pemphigus foliaceus after COVID-19 infection.
    J Med Virol. 2023;95:e28867.
    >> Share

  437. TRAGNI V, Mercurio I, Paoletti DP, Onofrio A, et al
    Deconstructing SARS-CoV-2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD.
    J Med Virol. 2023;95:e28875.
    >> Share

  438. LUO J, Zhang J, Tang HT, Wong HK, et al
    Prevalence and risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong.
    J Med Virol. 2023;95:e28862.
    >> Share

  439. YETMAR ZA, Yao JD, Razonable RR
    SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients.
    J Med Virol. 2023;95:e28885.
    >> Share

  440. ZHENG L, Wang L, Lu F
    Looking back on the outbreak of acute severe hepatitis with unknown etiology in children in 2022: What do we know now and where do we go from here?
    J Med Virol. 2023;95:e28890.
    >> Share

  441. AMANI B, Akbarzadeh A, Amani B, Shabestan R, et al
    Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID-19: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28889.
    >> Share

    May 2023
  442. MUHAMMED OA, Tawfeeq HM, Al-Jaf SMA, Niranji SS, et al
    Comments on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".
    J Med Virol. 2023;95:e28822.
    >> Share

  443. SONG R, Chen X, Li B, Zhang H, et al
    Nasal spray of an IgM-like ACE2 fusion protein HH-120 accelerates SARS-CoV-2 clearance: A single-center propensity score-matched cohort study.
    J Med Virol. 2023;95:e28805.
    >> Share

  444. ALI AM, Tofiq AM, Rostam HM, Ali KM, et al
    Response to comments to the editor on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".
    J Med Virol. 2023;95:e28820.
    >> Share

  445. ALI AM, Tofiq AM, Rostam HM, Ali KM, et al
    Corrigendum on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".
    J Med Virol. 2023;95:e28824.
    >> Share

  446. VARGHESE R, Pai S, Kumar D, Sharma R, et al
    SARS-CoV-2 XBB.1.16 variant: India in focus?
    J Med Virol. 2023;95:e28829.
    >> Share

  447. PARCZEWSKI M, Kufel J, Aksak-Was B, Piwnik J, et al
    Artificial neural network based prediction of the lung tissue involvement as an independent in-hospital mortality and mechanical ventilation risk factor in COVID-19.
    J Med Virol. 2023;95:e28787.
    >> Share

  448. ZHANG Y, Liu J, Li H, Yuan F, et al
    Comparison of the immunogenicity of nasal-spray rVSV vector, adenovirus vector, and inactivated COVID-19-based vaccines in rodent models.
    J Med Virol. 2023;95:e28806.
    >> Share

  449. SONG J, Wu Y, Yin X, Ma H, et al
    The causal links between gut microbiota and COVID-19: A Mendelian randomization study.
    J Med Virol. 2023;95:e28784.
    >> Share

  450. ZENG G, He F, Zhang X, Li G, et al
    Antibody response to the third dose of inactivated COVID-19 vaccine in people living with HIV (PLWH): A longitudinal cohort.
    J Med Virol. 2023;95:e28797.
    >> Share

  451. BEGUM F, Srivastava AK, Tripathi PP, Ray U, et al
    A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.
    J Med Virol. 2023;95:e28796.
    >> Share

  452. LIU TH, Huang PY, Wu JY, Chuang MH, et al
    Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world data.
    J Med Virol. 2023;95:e28801.
    >> Share

  453. YIN Y, Lin J, Yuan S, Tong S, et al
    Vaccination status for mild and asymptomatic infections with SARS-CoV-2 Omicron BA.2 variant in Shanghai.
    J Med Virol. 2023;95:e28767.
    >> Share

  454. HUESPE IA, Ferraris A, Lalueza A, Valdez PR, et al
    COVID-19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study.
    J Med Virol. 2023;95:e28786.
    >> Share

  455. SEVGI DY, Demirbas ND, Genc Yaman I, Derin O, et al
    Evaluation of the late presentation and associated factors of people living with HIV in Turkey.
    J Med Virol. 2023;95:e28781.
    >> Share

  456. CHEN L, Zhang Q, Li H, Ma K, et al
    Clinical considerations for a gastric Dieulafoy's disease patient: Cardiac arrhythmias caused by SARS-CoV-2 or terlipressin?
    J Med Virol. 2023;95:e28792.
    >> Share

  457. OGUNBAYO AE, Mogotsi MT, Sondlane H, Sabiu S, et al
    Metagenomics characterization of respiratory viral RNA pathogens in children under five years with severe acute respiratory infection in the Free State, South Africa.
    J Med Virol. 2023;95:e28753.
    >> Share

  458. FONG SW, Goh YS, Torres-Ruesta A, Chang ZW, et al
    Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection.
    J Med Virol. 2023;95:e28774.
    >> Share

  459. WANLAPAKORN N, Kanokudom S, Phowatthanasathian H, Chansaenroj J, et al
    Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years.
    J Med Virol. 2023;95:e28758.
    >> Share

  460. RIAD A, Schulz-Weidner N, Dziedzic A, Howaldt HP, et al
    Oral side effects of COVID-19 vaccines in 32 European countries: Analysis of EudraVigilance reports.
    J Med Virol. 2023;95:e28771.
    >> Share

  461. TIRELLI U, Franzini M, Chirumbolo S
    Post-COVID syndrome, the real matter of debate.
    J Med Virol. 2023;95:e28785.
    >> Share

  462. QIU S, Zheng K, Hu Y, Liu G, et al
    Genetic correlation, causal relationship, and shared loci between vitamin D and COVID-19: A genome-wide cross-trait analysis.
    J Med Virol. 2023;95:e28780.
    >> Share

  463. FORTHAL DN
    Comment on the immunogenicity of the Noora vaccine against SARS-CoV-2.
    J Med Virol. 2023;95:e28731.
    >> Share

  464. SAKAI-TAGAWA Y, Yamayoshi S, Halfmann PJ, Wilson N, et al
    Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2.
    J Med Virol. 2023;95:e28788.
    >> Share

  465. SCHUURMANS STEKHOVEN SJ, Winkel KGT, Souverein D, Sondermeijer BM, et al
    Clinical validation of novel dried blood spot based collecting device using serum separation for measuring SARS-CoV-2 antibodies.
    J Med Virol. 2023;95:e28765.
    >> Share

  466. ZHANG Y, Clarke SP, Wu H, Li W, et al
    A comprehensive overview on the transmission, pathogenesis, diagnosis, treatment, and prevention of SARS-CoV-2.
    J Med Virol. 2023;95:e28776.
    >> Share

  467. NASCIMENTO JHFD, Andrade AB, Gusmao-Cunha A, Cunha AMG, et al
    Trends in the morbidity and mortality of coronavirus disease 2019 in different ethnic groups and gender in a large Brazilian city.
    J Med Virol. 2023;95:e28794.
    >> Share

    April 2023
  468. WU J, Liu W, Zhu L, Li N, et al
    Dysbiosis of oropharyngeal microbiome and antibiotic resistance in hospitalized COVID-19 patients.
    J Med Virol. 2023;95:e28727.
    >> Share

  469. BOUKHALFA Y, Stambouli N, Driss A, Daiki M, et al
    sCXCL16 as a prognostic biomarker for COVID-19 outcome.
    J Med Virol. 2023;95:e28728.
    >> Share

  470. ZHANG N, Qi X, Chang H, Li C, et al
    Combined effects of inflammation and coronavirus disease 2019 (COVID-19) on the risks of anxiety and depression: A cross-sectional study based on UK Biobank.
    J Med Virol. 2023;95:e28726.
    >> Share

  471. MENG M, Wu Y, Sha W, Zeng R, et al
    Associations of habitual glucosamine use with SARS-CoV-2 infection and hospital admission and death with COVID-19: Evidence from a large population based cohort study.
    J Med Virol. 2023;95:e28720.
    >> Share

  472. PATINO LH, Ballesteros N, Munoz M, Ramirez AL, et al
    Mu SARS-CoV-2 (B.1.621) variant: A genomic snapshot across the Colombian-Venezuelan border.
    J Med Virol. 2023;95:e28766.
    >> Share

  473. LI J, Bai H, Qiao H, Du C, et al
    Causal effects of COVID-19 on cancer risk: A Mendelian randomization study.
    J Med Virol. 2023;95:e28722.
    >> Share

  474. CENAT JM, Moshirian Farahi SMM, Bakombo SM, Dalexis RD, et al
    Vaccine mistrust among Black individuals in Canada: The major role of health literacy, conspiracy theories, and racial discrimination in the healthcare system.
    J Med Virol. 2023;95:e28738.
    >> Share

  475. CAMACHO J, Albert E, Alvarez-Rodriguez B, Rusu L, et al
    A machine learning model for predicting serum neutralizing activity against Omicron SARS-CoV-2 BA.2 and BA.4/5 sublineages in the general population.
    J Med Virol. 2023;95:e28739.
    >> Share

  476. SHANG W, Zhang S, Qian H, Pan X, et al
    Association of gut microbiota with COVID-19 susceptibility and severity: A two-sample Mendelian randomization study.
    J Med Virol. 2023;95:e28734.
    >> Share

  477. ZHAO Y, Zhao Y, Su X, Zhou Y, et al
    No association of vaccination with inactivated COVID-19 vaccines before conception with pregnancy complications and adverse birth outcomes: A cohort study of 5457 Chinese pregnant women.
    J Med Virol. 2023;95:e28735.
    >> Share

  478. VANLERBERGHE B, Vrij C, Bogaerts K, Vermeersch P, et al
    SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients.
    J Med Virol. 2023;95:e28736.
    >> Share

  479. LU T, Chen Z, Cao Y, Ao L, et al
    Dynamic immunogenicity after primary and booster inactivated SARS-CoV-2 vaccination in people living with HIV: A longitudinal observational study.
    J Med Virol. 2023;95:e28730.
    >> Share

  480. CHEN YC, Ho CH, Liu TH, Wu JY, et al
    Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients.
    J Med Virol. 2023;95:e28745.
    >> Share

  481. YE J, Shao X, Yang Y, Zhu F, et al
    Predicting the negative conversion time of nonsevere COVID-19 patients using machine learning methods.
    J Med Virol. 2023;95:e28747.
    >> Share

  482. ONG DSY, de Man P, Verhagen T, Doejaaren G, et al
    Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.
    J Med Virol. 2023;95:e28748.
    >> Share

  483. SAENZ-ALDEA M, Salgado-Barreira A, Taracido-Trunk M, Pineiro-Lamas M, et al
    RE: Colchicine and risk of hospitalization due to COVID-19: A population-based study.
    J Med Virol. 2023;95:e28741.
    >> Share

  484. CHEN L, Shao Z, Liu H, Shi Q, et al
    Clinical observation of neutralizing antibody DXP-604 for treatment critical COVID-19 patients infected with SARS-CoV-2 Delta variant.
    J Med Virol. 2023;95:e28742.
    >> Share

  485. NING J, Wang Q, Chen Y, He T, et al
    Immunodominant SARS-CoV-2-specific CD4(+) and CD8(+) T-cell responses elicited by inactivated vaccines in healthy adults.
    J Med Virol. 2023;95:e28743.
    >> Share

  486. CHEEMA HA, Rehman AU, Elrashedy AA, Mohsin A, et al
    Antiandrogens for the treatment of COVID-19 patients: A meta-analysis of randomized controlled trials.
    J Med Virol. 2023;95:e28740.
    >> Share

  487. MAO S, Cai X, Niu S, Wei J, et al
    TRIM21 promotes ubiquitination of SARS-CoV-2 nucleocapsid protein to regulate innate immunity.
    J Med Virol. 2023;95:e28719.
    >> Share

  488. DENG G, Li D, Sun Y, Jin L, et al
    Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.
    J Med Virol. 2023;95:e28756.
    >> Share

  489. CHUANG MH, Wu JY, Liu TH, Hsu WH, et al
    Efficacy of nirmatrelvir and ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection.
    J Med Virol. 2023;95:e28750.
    >> Share

  490. QUDUS MS, Tian M, Sirajuddin S, Liu S, et al
    The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
    J Med Virol. 2023;95:e28751.
    >> Share

  491. TIAN F, Chen Z, Feng Q
    Nirmatrelvir-ritonavir compared with other antiviral drugs for the treatment of COVID-19 patients: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28732.
    >> Share

  492. SIMADIBRATA DM, Lesmana E, Pratama MIA, Annisa NG, et al
    Gastrointestinal Symptoms of Monkeypox Infection: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28709.
    >> Share

    March 2023
  493. SCARPA F, Giovanetti M, Azzena I, Locci C, et al
    Genome-based survey of the SARS-CoV-2 BF.7 variant from Asia.
    J Med Virol. 2023 Mar 31. doi: 10.1002/jmv.28714.
    >> Share

  494. LUO G
    Enhancement of SARS-CoV-2 infection and growth by an ACE2-specific monoclonal antibody.
    J Med Virol. 2023 Mar 28. doi: 10.1002/jmv.28711.
    >> Share

  495. ZHENG XQ, Xu QY, Xie L, He Y, et al
    Response and Duration of Serum Anti-SARS-CoV-2 Antibodies Induced by the Third Dose of an Inactivated Vaccine: A Prospective Longitudinal Cohort Study at 21 Serial Time Points over 641 Days.
    J Med Virol. 2023 Mar 25. doi: 10.1002/jmv.28703.
    >> Share

  496. ZHANG Z, Shao S, Liu X, Tong Z, et al
    Effect and safety of mesenchymal stem cells for patients with COVID-19: systematic review and meta-analysis with trial sequential analysis.
    J Med Virol. 2023 Mar 25. doi: 10.1002/jmv.28702.
    >> Share

  497. BARANOVA A, Cao H, Zhang F
    Causal associations and shared genetics between hypertension and COVID-19.
    J Med Virol. 2023 Mar 23. doi: 10.1002/jmv.28698.
    >> Share

  498. ADEN D, Zaheer S, Kumar R, Ranga S, et al
    Monkeypox (Mpox) outbreak during COVID-19 pandemic - Past and the future.
    J Med Virol. 2023 Mar 23. doi: 10.1002/jmv.28701.
    >> Share

  499. MANNAN A, Hoque MN, Noyon SH, Hamidullah Mehedi HM, et al
    SARS-CoV-2 infection alters the gut microbiome in diabetes patients: A cross-sectional study from Bangladesh.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28691.
    >> Share

  500. CHANG HC, Gau SY
    Colchicine and risk of COVID-19-associated hospitalization.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28690.
    >> Share

  501. CHEN Z, Huang T, He T, Zha G, et al
    Humoral responses after primary and booster SARS-CoV-2 inactivated vaccination in patients with chronic hepatitis B virus infection: a longitudinal observational study.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28695.
    >> Share

  502. CHEUNG AKL, Lu Y, Zhu Y, Fung TY, et al
    Consistent neutralization of circulating omicron sub-variants by hybrid immunity up to 6 months after booster vaccination.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28694.
    >> Share

  503. MAI W, Ren Y, Tian X, Al-Mahdi AY, et al
    Comparison of Common Human Respiratory Pathogens Among Hospitalized Children aged
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28692.
    >> Share

  504. DA SILVA AS, Campos GM, Giovanetti M, Zucherato VS, et al
    VIRAL METAGENOMICS UNVEILS MW (MALAWI) POLYOMAVIRUS INFECTION IN BRAZILIAN PEDIATRIC PATIENTS WITH ACUTE RESPIRATORY DISEASE.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28688.
    >> Share

  505. MAHROUM N, Elsalti A, Shoenfeld Y
    Commentary: Herpes simplex virus and SLE: though uncommon yet with significant implications.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28689.
    >> Share

  506. ZHANG Y, Lu M, Thongpan I, Xu J, et al
    Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS-CoV-2 infection.
    J Med Virol. 2023 Mar 20. doi: 10.1002/jmv.28687.
    >> Share

  507. BOJKOVA D, Bechtel M, Rothenburger T, Kandler JD, et al
    Omicron-induced interferon signalling prevents influenza A H1N1 and H5N1 virus infection.
    J Med Virol. 2023 Mar 20. doi: 10.1002/jmv.28686.
    >> Share

  508. BIANCONI V, Mannarino MR, Cosentini E, Figorilli F, et al
    The impact of statin therapy on in-hospital prognosis and endothelial function of patients at high-to-very high cardiovascular risk admitted for COVID-19: Statins, endothelial function, and COVID-19 outcomes.
    J Med Virol. 2023 Mar 17. doi: 10.1002/jmv.28678.
    >> Share

  509. GARCIA-PEREZ J, Bermejo M, Ramirez-Garcia A, Torre Tarazona HE, et al
    Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern.
    J Med Virol. 2023 Mar 17. doi: 10.1002/jmv.28679.
    >> Share

  510. DENG J, Zheng SN, Xiao Y, Nan ML, et al
    SARS-CoV-2 NSP8 suppresses type I and III IFN responses by modulating the RIG-I/MDA5, TRIF, and STING signaling pathways.
    J Med Virol. 2023 Mar 17. doi: 10.1002/jmv.28680.
    >> Share

  511. KWON HJ, Zhang J, Kosikova M, Tang W, et al
    Distinct In Vitro and In Vivo Neutralization Profiles of Monoclonal Antibodies Elicited by the Receptor Binding Domain of the Ancestral SARS-CoV-2.
    J Med Virol. 2023 Mar 14. doi: 10.1002/jmv.28673.
    >> Share

  512. YU D, Zhao ZY, Yang YL, Qin Y, et al
    The origin and evolution of emerged swine acute diarrhea syndrome coronavirus with zoonotic potential.
    J Med Virol. 2023 Mar 14. doi: 10.1002/jmv.28672.
    >> Share

  513. FAN Z, Ruan Z, Liuzhi, Guo B, et al
    Causal association of the brain structure with the susceptibility, hospitalisation, and severity of COVID-19: A large-scale genetic correlation study.
    J Med Virol. 2023 Mar 13. doi: 10.1002/jmv.28651.
    >> Share

  514. KAN Q, Lin X, Li T, Ke X, et al
    A novel mAb broadly neutralizes SARS-CoV-2 VOCs in vitro and in vivo, including the Omicron variants.
    J Med Virol. 2023 Mar 13. doi: 10.1002/jmv.28657.
    >> Share

  515. UYGUR A, Sayili U
    Letter to the Editor: The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer.
    J Med Virol. 2023 Mar 11. doi: 10.1002/jmv.28664.
    >> Share

  516. MAZZITELLI M, Trunfio M, Sasset L, Scaglione V, et al
    Risk of hospitalization and sequelae in patients with COVID-19 treated with 3-day early remdesivir vs. controls in the vaccine and Omicron era: a real-life cohort study.
    J Med Virol. 2023 Mar 11. doi: 10.1002/jmv.28660.
    >> Share

  517. GAO L, Gao Y, Han K, Wang Z, et al
    FBXO11 amplifies type I interferon signaling to exert antiviral effects by facilitating the assemble of TRAF3-TBK1-IRF3 complex.
    J Med Virol. 2023 Mar 10. doi: 10.1002/jmv.28655.
    >> Share

  518. JIA T, Wu Y, Liao G, Lei Y, et al
    Stable and durable antibody responses in SARS-recovered donors vaccinated with inactivated SARS-CoV-2 vaccine.
    J Med Virol. 2023 Mar 10. doi: 10.1002/jmv.28662.
    >> Share

  519. KELLER K, Sagoschen I, Konstantinides S, Gori T, et al
    Incidence and risk factors of myocarditis in hospitalized patients with COVID-19.
    J Med Virol. 2023 Mar 9. doi: 10.1002/jmv.28646.
    >> Share

  520. GUO Z, Zhao S, Mok CKP, So RTY, et al
    Comparing the incubation period, serial interval, and infectiousness profile between SARS-CoV-2 Omicron and Delta variants.
    J Med Virol. 2023 Mar 9. doi: 10.1002/jmv.28648.
    >> Share

  521. XIA S, Jiao F, Wang L, Yu X, et al
    SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.
    J Med Virol. 2023 Mar 8. doi: 10.1002/jmv.28641.
    >> Share

  522. YI X, Wang Y, Li Q, Li X, et al
    Pre-existing immunity to SARS-CoV-2 associates with strong T cell responses induced by inactivated COVID-19 vaccines.
    J Med Virol. 2023 Mar 8. doi: 10.1002/jmv.28642.
    >> Share

  523. CORMA-GOMEZ A, Fernandez-Fuertes M, Vinuela L, Dominguez C, et al
    Reduced neutralizing antibody response to SARS-CoV-2 vaccine booster dose in people living with HIV with severe immunosuppression.
    J Med Virol. 2023 Mar 6. doi: 10.1002/jmv.28602.
    >> Share

  524. LY H
    SARS-CoV-2 infection of kidney tissues in some severe and fatal cases of COVID-19.
    J Med Virol. 2023 Mar 6. doi: 10.1002/jmv.28636.
    >> Share

  525. KUITUNEN I
    No signs of "tripledemic" in Finnish children.
    J Med Virol. 2023 Mar 2. doi: 10.1002/jmv.28631.
    >> Share

  526. WANG W, Qu Y, Wang X, Xiao MZX, et al
    Genetic variety of ORF3a shapes SARS-CoV-2 fitness through modulation of lipid droplet.
    J Med Virol. 2023 Mar 2. doi: 10.1002/jmv.28630.
    >> Share

  527. KIM D, Kim J, An S, Kim M, et al
    In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein.
    J Med Virol. 2023 Mar 1. doi: 10.1002/jmv.28626.
    >> Share

  528. SAHIN A, Karadag-Oncel E, Buyuksen O, Ekemen-Keles Y, et al
    The diversity in the clinical features of children hospitalized with COVID-19 during the nonvariant, Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529) variant periods of SARS CoV-2: Caution for neurological symptoms in Omicron variant.
    J Med Virol. 2023 Mar 1. doi: 10.1002/jmv.28628.
    >> Share

    February 2023
  529. SCARPA F, Sanna D, Azzena I, Casu M, et al
    Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages.
    J Med Virol. 2023 Feb 28. doi: 10.1002/jmv.28625.
    >> Share

  530. ZHANG J, Yang W, Huang F, Zhang K, et al
    Effectiveness of mRNA and viral-vector vaccines in epidemic period led by different SARS-CoV-2 variants: a systematic review and meta-analysis.
    J Med Virol. 2023 Feb 28. doi: 10.1002/jmv.28623.
    >> Share

  531. HUANG PY, Liu TH, Wu JY, Tsai YW, et al
    Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials.
    J Med Virol. 2023 Feb 27. doi: 10.1002/jmv.28621.
    >> Share

  532. LEE AR, Kweon YC, Lee SM, Park CY, et al
    Human coronavirus 3CL proteases cleave Septins and disrupt Hedgehog signaling, causing ciliary dysfunction.
    J Med Virol. 2023 Feb 24. doi: 10.1002/jmv.28618.
    >> Share

  533. CHEN JM, Gong HY, Chen RX, Liu ST, et al
    Features and significance of the recent enormous COVID-19 epidemic in China.
    J Med Virol. 2023 Feb 24. doi: 10.1002/jmv.28616.
    >> Share

  534. FENG Z, Huo D, Cui S, Lvy B, et al
    Epidemiological features, genomic characteristics, and origin tracing of the COVID-19 outbreaks in Beijing from January to September 2022.
    J Med Virol. 2023 Feb 24. doi: 10.1002/jmv.28613.
    >> Share

  535. CHEN Z, Du R, Cooper L, Achi JG, et al
    Sulforaphane is a reversible covalent inhibitor of 3-chymotrypsin-like protease of SARS-CoV-2.
    J Med Virol. 2023 Feb 24. doi: 10.1002/jmv.28609.
    >> Share

  536. TAKAHASHI K, Saito M, Sekizuka T, Itokawa K, et al
    Emergence of BS.1 and BS.1.1, highly mutated new SARS-CoV-2 Omicron variants.
    J Med Virol. 2023 Feb 24. doi: 10.1002/jmv.28615.
    >> Share

  537. ZHANG S, Ju J, Yang F, Zheng C, et al
    Ocular Tropism of SARS-CoV-2 Infection.
    J Med Virol. 2023 Feb 23. doi: 10.1002/jmv.28594.
    >> Share

  538. JAMAATI H, Karimi S, Ghorbani F, Panahi Y, et al
    Effectiveness of Different Vaccine Platforms in Reducing Mortality and Length of ICU Stay in Severe and Critical Cases of COVID-19 in the Omicron Variant Era: A National Cohort Study in Iran.
    J Med Virol. 2023 Feb 23. doi: 10.1002/jmv.28607.
    >> Share

  539. WANG Y, Shi L, Liu D, Mao Y, et al
    Changes in Epstein-Barr virus infections in the children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Med Virol. 2023 Feb 23. doi: 10.1002/jmv.28597.
    >> Share

  540. BRANDA F, Scarpa F, Ciccozzi M, Maruotti A, et al
    Is a new COVID-19 wave coming from China due to an unknown variant of concern? Keep calm and look at the data.
    J Med Virol. 2023 Feb 23. doi: 10.1002/jmv.28601.
    >> Share

  541. CHEN Y, Xue Y, Yang J
    Gilteritinib: Repurposing of AXL-targeting kinase inhibitors against COVID-19.
    J Med Virol. 2023 Feb 21. doi: 10.1002/jmv.28592.
    >> Share

  542. RECTOR A, Bloemen M, Thijssen M, Delang L, et al
    Monitoring of SARS-CoV-2 concentration and circulation of variants of concern in wastewater of Leuven, Belgium.
    J Med Virol. 2023 Feb 17. doi: 10.1002/jmv.28587.
    >> Share

  543. ZHU Z, Chen X, Wang C, Zhang S, et al
    An integrated strategy to identify COVID-19 causal genes and characteristics represented by LRRC37A2.
    J Med Virol. 2023 Feb 16. doi: 10.1002/jmv.28585.
    >> Share

  544. GERMANO MJ, Giai C, Cargnelutti DE, Colombo MI, et al
    Receptor-binding domain-based SARS-CoV-2 vaccine adjuvanted with cyclic di-adenosine monophosphate enhances humoral and cellular immunity in mice.
    J Med Virol. 2023 Feb 16. doi: 10.1002/jmv.28584.
    >> Share

  545. STICH M, Benning L, Speer C, Garbade SF, et al
    Live-virus neutralization of the omicron variant in children and adults 14 months after SARS-CoV-2 wild-type infection.
    J Med Virol. 2023 Feb 16. doi: 10.1002/jmv.28582.
    >> Share

  546. LIN Z, Sun L, Li L, Jiang S, et al
    Nasal mucosa is much more susceptible than oral mucosa to infection of SARS-CoV-2 Omicron subvariants: wearing nasal masks where facial masks cannot be used.
    J Med Virol. 2023 Feb 13. doi: 10.1002/jmv.28577.
    >> Share

  547. RZYMSKI P, Szuster-Ciesielska A, Dzieciatkowski T, Gwenzi W, et al
    mRNA vaccines: The future of prevention of viral infections?
    J Med Virol. 2023 Feb 10. doi: 10.1002/jmv.28572.
    >> Share

  548. YAO M, Huang X, Guo Y, Zhao JV, et al
    Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID-19 outcomes: genome-wide cross trait analysis and bi-directional Mendelian randomization study.
    J Med Virol. 2023 Feb 10. doi: 10.1002/jmv.28570.
    >> Share

  549. RADOVIC S, Meng W, Chen L, Paniz Mondolfi AE, et al
    SARS-CoV-2 infection of kidney tissues from severe COVID-19 patients.
    J Med Virol. 2023 Feb 9. doi: 10.1002/jmv.28566.
    >> Share

  550. NICOT F, Tremeaux P, Latour J, Carcenac R, et al
    WHOLE-GENOME SINGLE MOLECULE REAL-TIME SEQUENCING OF SARS-CoV-2 OMICRON.
    J Med Virol. 2023 Feb 9. doi: 10.1002/jmv.28564.
    >> Share

  551. WANG X, Yang Y, Song Z, Wang Y, et al
    Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants.
    J Med Virol. 2023 Feb 9. doi: 10.1002/jmv.28565.
    >> Share

  552. CRADDOCK V, Mahajan A, Spikes L, Krishnamachary B, et al
    Persistent Circulation of Soluble and Extracellular vesicle-linked Spike Protein in Individuals with Post-Acute Sequelae of COVID-19.
    J Med Virol. 2023 Feb 9. doi: 10.1002/jmv.28568.
    >> Share

  553. ZHANG T, Wang Z, Yang J, Xu X, et al
    Immunogenicity of novel DNA vaccines encoding receptor-binding domain (RBD) dimer-Fc fusing antigens derived from different SARS-CoV-2 variants of concern.
    J Med Virol. 2023 Feb 8. doi: 10.1002/jmv.28563.
    >> Share

  554. DUTTA D, Ghosh A, Dutta C, Sukla S, et al
    Cross reactivity of SARS-CoV-2 with other pathogens, especially dengue virus: A historical perspective.
    J Med Virol. 2023 Feb 8. doi: 10.1002/jmv.28557.
    >> Share

  555. KANG CK, Kim MG, Park SW, Kim YW, et al
    Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naive individuals.
    J Med Virol. 2023 Feb 8. doi: 10.1002/jmv.28558.
    >> Share

  556. DENG J, Zheng Y, Zheng SN, Nan ML, et al
    SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.
    J Med Virol. 2023 Feb 8. doi: 10.1002/jmv.28561.
    >> Share

  557. CHEN J, Cheng X, Xu Y, Shi T, et al
    Analysis on the Physiological Changes of Residents Before and During the COVID-19 Pandemic: A Cross-Sectional Study.
    J Med Virol. 2023 Feb 8. doi: 10.1002/jmv.28562.
    >> Share

  558. TONYALI A, Karacetin G, Yesilkaya C, Arik FNT, et al
    Appearance of extrapyramidal symptoms in adolescent psychiatry patients during Covid-19 infection.
    J Med Virol. 2023 Feb 4. doi: 10.1002/jmv.28556.
    >> Share

  559. GUO Y, Guo Y, Zhang Y, Li F, et al
    Factors Affecting Prolonged SARS-CoV-2 Infection and Development and Validation of Predictive Nomograms.
    J Med Virol. 2023 Feb 3. doi: 10.1002/jmv.28550.
    >> Share

  560. WEI B, Liu Y, Li H, Peng Y, et al
    Impact of alcohol consumption on COVID-19 severity: A systematic review and meta-analysis.
    J Med Virol. 2023 Feb 3. doi: 10.1002/jmv.28547.
    >> Share

  561. AKIF A, Bhuiyan MA, Islam MR
    SARS-COV-2 omicron subvariant BF.7 is again triggering the Covid fear: What we need to know and what we should do?
    J Med Virol. 2023 Feb 3. doi: 10.1002/jmv.28551.
    >> Share

  562. KHAN A, Imran K, Zhu G, Ji J, et al
    Discovery of Isojacareubin as a covalent inhibitor of SARS-CoV-2 main protease using structural and experimental approaches.
    J Med Virol. 2023 Feb 2. doi: 10.1002/jmv.28542.
    >> Share

  563. TORRE-TARAZONA E, Gonzalez-Robles A, Cascajero A, Jimenez P, et al
    Treatment with integrase inhibitors alters SARS-CoV-2 neutralization levels measured with HIV-based pseudotypes in people living with HIV.
    J Med Virol. 2023 Feb 2. doi: 10.1002/jmv.28543.
    >> Share

  564. BAIOCCHI GC, Vojdani A, Rosenberg AZ, Vojdani E, et al
    Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.
    J Med Virol. 2023 Feb 1. doi: 10.1002/jmv.28538.
    >> Share

  565. WANG X, He X, Jiang S, Fu Z, et al
    Limited enhancement of antibody and B-cell responses to prototype booster vaccination following SARS-CoV-2 Delta breakthrough infection.
    J Med Virol. 2023 Feb 1. doi: 10.1002/jmv.28540.
    >> Share

  566. KORSUN N, Trifonova I, Dobrinov V, Madzharova I, et al
    Low prevalence of influenza viruses and predominance of A(H3N2) virus with respect to SARS-CoV-2 during the 2021-2022 season in Bulgaria.
    J Med Virol. 2023;95:e28489.
    >> Share

  567. SKINNER JP, Moran LV
    Persistent effects of COVID-19 in patients hospitalized during the first wave of the pandemic: The impact of persistent fatigue on quality of life in a cross-sectional study.
    J Med Virol. 2023;95:e28491.
    >> Share

  568. KUMARI D, Singh Y, Singh S, Dogra V, et al
    "Mitochondrial pathogenic mutations and metabolic alterations associated with COVID-19 disease severity".
    J Med Virol. 2023;95:e28553.
    >> Share

    January 2023
  569. CHEN Z, Li J, Zheng J, Jin Y, et al
    Emerging Omicron subvariants evade neutralizing immunity elicited by vaccine or BA.1/BA.2 infection.
    J Med Virol. 2023 Jan 31. doi: 10.1002/jmv.28539.
    >> Share

  570. HEYDECKE A, Gullsby K
    Evaluation of the performance of a rapid antigen test (Roche) for COVID-19 diagnosis in an emergency setting in Sweden.
    J Med Virol. 2023 Jan 30. doi: 10.1002/jmv.28537.
    >> Share

  571. QUAN NK, Thien DH, Huy NT
    Detect and suppress future zoonotic-derived outbreaks: A lesson from last two decades.
    J Med Virol. 2023 Jan 30. doi: 10.1002/jmv.28530.
    >> Share

  572. SUN C, Yau V, Uy JPN, Lowe S, et al
    Does viral inoculum play a role in disease severity in COVID-19?
    J Med Virol. 2023 Jan 27. doi: 10.1002/jmv.28532.
    >> Share

  573. WANG J, Yin X, Yu L, Cheng W, et al
    Delayed cutaneous hypersensitivity reactions following the use of infliximab or adalimumab in patients with coronavirus disease 2019.
    J Med Virol. 2023 Jan 26. doi: 10.1002/jmv.28518.
    >> Share

  574. BONGIOVANNI M, Barilaro G, Bini F
    Twelve-month clinical, functional and radiological outcomes in patients hospitalized for SARS-CoV-2 pneumonia.
    J Med Virol. 2023 Jan 25. doi: 10.1002/jmv.28524.
    >> Share

  575. SHIRAZ R, Tripathi S
    Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape.
    J Med Virol. 2023 Jan 24. doi: 10.1002/jmv.28519.
    >> Share

  576. KIM K, Cho K, Song J, Rahmati M, et al
    The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis.
    J Med Virol. 2023 Jan 24. doi: 10.1002/jmv.28522.
    >> Share

  577. SHEN F, Yang CX, Lu Y, Zhang M, et al
    Significant neutralizing escapes of Omicron and its sub-lineages in SARS-CoV-2-infected individuals vaccinated with inactivated vaccines.
    J Med Virol. 2023 Jan 21. doi: 10.1002/jmv.28516.
    >> Share

  578. ROBERTO P, Cinti L, Napoli A, Paesani D, et al
    Torque teno virus (TTV): a gentle spy virus of immune status, predictive marker of seroconversion to COVID-19 vaccine in kidney and lung transplant recipients.
    J Med Virol. 2023 Jan 20. doi: 10.1002/jmv.28512.
    >> Share

  579. LIAN XY, Xi L, Zhang ZS, Yang LL, et al
    Impact of air pollutants on influenza-like illness outpatient visits under COVID-19 pandemic in the sub-center of Beijing, China.
    J Med Virol. 2023 Jan 20. doi: 10.1002/jmv.28514.
    >> Share

  580. ZHAO Y, Du J, Li Z, Wu Y, et al
    It Is Time to Improve the Acceptance of COVID-19 Vaccines Among People with Chronic Diseases: A Systematic Review and Meta-analysis.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28509.
    >> Share

  581. HASSEBROEK AM, Sooryanarain H, Lynn Heffron C, Hawks SA, et al
    A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infection.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28503.
    >> Share

  582. HARADA KH, Phosri A
    A protocol of trial of ivermectin in COVID-19 treatment critically changed after its completion.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28505.
    >> Share

  583. MATIC S, Milovanovic D, Mijailovic Z, Djurdjevic P, et al
    IFNL3/4 polymorphisms as a two-edged sword: an association with COVID-19 outcome.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28506.
    >> Share

  584. ABD-ELSALAM S, Medhat MA, Ramadan HK, Soliman S, et al
    Reply to letter to the editor.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28502.
    >> Share

  585. PAN J, Yang S, Chen X, Che X, et al
    Two-year impact of COVID-19 pandemic on hospitalized patients with skin diseases in China.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28511.
    >> Share

  586. ERDIK B
    Covid Associated Immune Dysfunction (CAID) Leading to Increased Pediatric Hospitalizations.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28508.
    >> Share

  587. QI T, Jin Y, Wang H, Liao Y, et al
    Nirmatrelvir-ritonavir Therapy and COVID-19 Vaccination Improve Clinical Outcomes of SARS-CoV-2 Omicron Variant Infection.
    J Med Virol. 2023 Jan 18. doi: 10.1002/jmv.28497.
    >> Share

  588. MORALES-ORTEGA A, Farfan-Sedano AI, Martin-Lopez JVS, Escriba-Barcena A, et al
    Baricitinib or imatinib in hospitalized COVID-19 patients: results from COVINIB, an exploratory randomized clinical trial.
    J Med Virol. 2023 Jan 13. doi: 10.1002/jmv.28495.
    >> Share

  589. ALDEA MS, Salgado-Barreira A, Trunk MT, Lamas MP, et al
    Colchicine and risk of hospitalisation due to COVID-19: a population-based study.
    J Med Virol. 2023 Jan 13. doi: 10.1002/jmv.28496.
    >> Share

  590. BERBER NK, Geckil AA, Altan NO, Kiran TR, et al
    Efficacy of Serum Apelin and Galectin-3 as Potential Predictors of Mortality in Severe COVID-19 Patients.
    J Med Virol. 2023 Jan 12. doi: 10.1002/jmv.28494.
    >> Share

  591. KIM SH, Baek JY, Han M, Lee M, et al
    A decrease in the incidence of encephalitis in South Korea during the COVID-19 pandemic: A nationwide study between 2010 and 2021.
    J Med Virol. 2023 Jan 11. doi: 10.1002/jmv.28490.
    >> Share

  592. XIONG N, Sun Q
    How does SARS-CoV-2 Infection impact on immunity, procession and treatment of Pan Cancers.
    J Med Virol. 2023 Jan 10. doi: 10.1002/jmv.28487.
    >> Share

  593. YADAV PD, Kumar S, Agarwal K, Jain M, et al
    Needle-free injection system delivery of ZyCoV-D DNA vaccine demonstrated improved immunogenicity and protective efficacy in Rhesus macaques against SARS-CoV-2.
    J Med Virol. 2023 Jan 10. doi: 10.1002/jmv.28484.
    >> Share

  594. WANG M, Huang L
    Letter to the Editor Regarding "Effects of inactivated SARS-CoV-2 vaccination on male fertility: a retrospective cohort study".
    J Med Virol. 2023 Jan 10. doi: 10.1002/jmv.28486.
    >> Share

  595. KRISHNAMOORTHY P, Raj AS, Kumar H
    Machine learning-driven blood transcriptome-based discovery of SARS-CoV-2 specific severity biomarkers.
    J Med Virol. 2023 Jan 10. doi: 10.1002/jmv.28488.
    >> Share

  596. HUANG HC, Wang SH, Fang GC, Chou WC, et al
    Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.
    J Med Virol. 2023 Jan 7. doi: 10.1002/jmv.28478.
    >> Share

  597. TENG L, Song X, Zhang M, Han Y, et al
    The pattern of cytokines expression and dynamic changes of renal function at 6 months in patients with Omicron COVID-19.
    J Med Virol. 2023 Jan 7. doi: 10.1002/jmv.28477.
    >> Share

  598. FARIAS JP, Pinheiro JR, Andreata-Santos R, Fogaca MMC, et al
    The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant.
    J Med Virol. 2023 Jan 7. doi: 10.1002/jmv.28481.
    >> Share

  599. CHEEMA HA, Jafar U, Sohail A, Shahid A, et al
    Nirmatrelvir-ritonavir for the treatment of COVID-19 patients: a systematic review and meta-analysis.
    J Med Virol. 2023 Jan 6. doi: 10.1002/jmv.28471.
    >> Share

  600. LEI Z, Zhu L, Pan P, Ruan Z, et al
    A vaccine delivery system promotes strong immune responses against SARS-CoV-2 variants.
    J Med Virol. 2023 Jan 6. doi: 10.1002/jmv.28475.
    >> Share

  601. LI X, Yin W, Li A, Li D, et al
    ACE2 PET to Reveal the Dynamic Patterns of ACE2 Recovery in an Infection Model with Pseudo Corona Virus.
    J Med Virol. 2023 Jan 6. doi: 10.1002/jmv.28470.
    >> Share

  602. CHUNG H, Ko H, Lee H, Yon DK, et al
    Development and validation of a deep learning model to diagnose COVID-19 using time-series heart rate values before the onset of symptoms.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28462.
    >> Share

  603. KWON R, Koo MJ, Lee SW, Choi YS, et al
    National trends in physical activity among adolescents in South Korea before and during the COVID-19 pandemic, 2009-2021.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28456.
    >> Share

  604. MERZA MA, Almufty HB, Younis HA, Rasool SO, et al
    Memory impairment among recovered COVID-19 patients: the prevalence and risk factors, a retrospective cohort study.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28459.
    >> Share

  605. VAEZI M, Ravanshad S, Rad MA, Zarrinfar H, et al
    The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID-19 patients: A randomized placebo-controlled trial.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28463.
    >> Share

  606. KOH LP, Chua SL, Vasoo S, Toh MPHS, et al
    Real-World Effectiveness of Sotrovimab and Remdesivir for Early Treatment of High-Risk Hospitalized COVID-19 Patients - a Propensity Score Adjusted Retrospective Cohort Study.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28460.
    >> Share

  607. TOWNSEND JP, Hassler HB, Dornburg A
    Infection by SARS-CoV-2 with alternate frequencies of mRNA vaccine boosting.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28461.
    >> Share

  608. PRADO CAS, Fonseca DLM, Singh Y, Filgueiras IS, et al
    Title: Integrative systems immunology uncovers molecular networks of the cell cycle that stratify COVID-19 severity.
    J Med Virol. 2023 Jan 4. doi: 10.1002/jmv.28450.
    >> Share

  609. LIU X, Du Z, Wang J, Wang Q, et al
    Association between trans fatty acids and COVID-19: a multivariate Mendelian randomization study.
    J Med Virol. 2023 Jan 4. doi: 10.1002/jmv.28455.
    >> Share

  610. KIRAZ A, Sezer O, Alemdar A, Canbek S, et al
    Contribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia.
    J Med Virol. 2023 Jan 4. doi: 10.1002/jmv.28457.
    >> Share

  611. BELTRAN DM, Villamil Osorio M, Fonseca SLG, Restrepo S, et al
    PREDICTORS OF SEVERITY IN SEVERE RESPIRATORY INFECTION IN CHILDREN WITH COVID-19 RESPIRATORY INFECTION IN A DEVELOPING COUNTRY.
    J Med Virol. 2023 Jan 3. doi: 10.1002/jmv.28453.
    >> Share

  612. FOCOSI D, Maggi F, Shoham S, Casadevall A, et al
    Discriminating endogenous vaccine-elicited anti-Spike antibody responses from exogenous anti-Spike monoclonal antibodies: The case of Evusheld.
    J Med Virol. 2023;95:e28277.
    >> Share

  613. LAI CJ, Kim D, Kang S, Li K, et al
    Viral codon optimization on SARS-CoV-2 Spike boosts immunity in the development of COVID-19 mRNA vaccines.
    J Med Virol. 2023;95:e29183.
    >> Share

    December 2022
  614. KIM JG, Zhang A, Rauseo AM, Goss CW, et al
    The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.
    J Med Virol. 2022 Dec 30. doi: 10.1002/jmv.28445.
    >> Share

  615. LUO J, Zhang J, Tang HT, Wong HK, et al
    Weekly Symptom Profiles of Non-hospitalized Individuals Infected with SARS-CoV-2 During the Omicron Outbreak in Hong Kong: A Retrospective Observational Study from a Telemedicine Centre.
    J Med Virol. 2022 Dec 30. doi: 10.1002/jmv.28447.
    >> Share

  616. WANG Y, Zhao D, Liu X, Chen X, et al
    Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS-CoV-2 omicron variants.
    J Med Virol. 2022 Dec 29. doi: 10.1002/jmv.28443.
    >> Share

  617. ACOSTA N, Bautista MA, Waddell BJ, Du K, et al
    Surveillance for SARS-CoV-2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreaks.
    J Med Virol. 2022 Dec 29. doi: 10.1002/jmv.28442.
    >> Share

  618. HOFFMANN AT, da Silva MS, Gularte JS, Pasqualotto AC, et al
    Dynamics of nosocomial SARS-CoV-2 transmissions: facing the challenge of variants of concern in a Brazilian reference hospital.
    J Med Virol. 2022 Dec 29. doi: 10.1002/jmv.28446.
    >> Share

  619. HUANG J, Yang X, Ren L, Jiang W, et al
    A novel, ultrafast, ultrasensitive diagnosis platform for the detection of SARS-COV-2 using restriction endonuclease-mediated reverse transcription multiple cross displacement amplification.
    J Med Virol. 2022 Dec 29. doi: 10.1002/jmv.28444.
    >> Share

  620. AMANI B, Amani B
    Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19 : a rapid review and meta-analysis.
    J Med Virol. 2022 Dec 28. doi: 10.1002/jmv.28441.
    >> Share

  621. LI S, Wu J, Jiang W, He H, et al
    Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies.
    J Med Virol. 2022 Dec 27. doi: 10.1002/jmv.28440.
    >> Share

  622. ZHANG GF, Meng W, Chen L, Ding L, et al
    Infectivity of pseudotyped SARS-CoV-2 variants of concern in different human cell types and inhibitory effects of recombinant spike protein and entry-related cellular factors.
    J Med Virol. 2022 Dec 27. doi: 10.1002/jmv.28437.
    >> Share

  623. LI T, Li X, Chen N, Yang J, et al
    Influence of the COVID-19 Pandemic on the Vitamin D Status of Children: A Cross-Sectional Study.
    J Med Virol. 2022 Dec 27. doi: 10.1002/jmv.28438.
    >> Share

  624. ZARUR-TORRALVO S, Stand-Nino I, Florez-Garcia V, Mendoza H, et al
    Viruses Responsible for Acute Respiratory Infections Before (2016-2019) and During (2021) Circulation of the SARS-CoV-2 virus in Pediatric Patients in a Reference Center at Barranquilla Colombia: A Pattern Analysis.
    J Med Virol. 2022 Dec 27. doi: 10.1002/jmv.28439.
    >> Share

  625. MACHADO TL, Santos AC, Azamor T, Vieira da Silva AM, et al
    CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID-19 therapy.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28427.
    >> Share

  626. LAI CC, Hsueh PR
    Coronavirus disease 2019 rebounds following nirmatrelvir/ritonavir treatment.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28430.
    >> Share

  627. BARANOVA A, Cao H, Teng S, Su KP, et al
    Shared genetics and causal associations between COVID-19 and multiple sclerosis.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28431.
    >> Share

  628. ZHAN H, Gao H, Liu Y, Zhang X, et al
    Booster shot of inactivated SARS-CoV-2 vaccine induces potent immune responses in people living with HIV.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28428.
    >> Share

  629. LI H, Cai D, Jiang D, Li X, et al
    Risk of waning humoral responses after inactivated or subunit recombinant SARS-CoV-2 vaccination in patients with chronic diseases: Findings from a prospective observational study in China.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28434.
    >> Share

  630. ZHAO Y, Zhao Y, Ai A, Jin L, et al
    Association of inactivated COVID-19 vaccination with in vitro fertilization and early pregnancy outcomes.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28432.
    >> Share

  631. LAI CC, Hsu CK, Hsueh SC, Yen MY, et al
    Multisystem inflammatory syndrome in adults: Characteristics, treatment, and outcomes.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28426.
    >> Share

  632. RUSSELL SL, Klaver BRA, Harrigan SP, Kamelian K, et al
    Clinical severity of Omicron sub-variants BA.1, BA.2 and BA.5 in a population-based cohort study in British Columbia, Canada.
    J Med Virol. 2022 Dec 22. doi: 10.1002/jmv.28423.
    >> Share

  633. MAHALINGAM G, Periyasami Y, Arjunan P, Subaschandrabose RK, et al
    Omicron infection increases IgG binding to spike protein of predecessor variants.
    J Med Virol. 2022 Dec 22. doi: 10.1002/jmv.28419.
    >> Share

  634. WANG Y, Chen X, Liu X, Zhao D, et al
    Nirmatrelvir-ritonavir might only be effective in elderly patients.
    J Med Virol. 2022 Dec 21. doi: 10.1002/jmv.28418.
    >> Share

  635. BANERJEE A, Mazumder A, Roy J, Das J, et al
    Emergence of a unique SARS-CoV-2 Delta sub-cluster harboring a constellation of co-appearing non-Spike mutations.
    J Med Virol. 2022 Dec 21. doi: 10.1002/jmv.28413.
    >> Share

  636. FOURIE E, Sijm YE, Badoux P, Merelle ME, et al
    High Detection Rate of Viral Pathogens in Nasal Discharge in Children Aged 0 till 5 Years.
    J Med Virol. 2022 Dec 21. doi: 10.1002/jmv.28415.
    >> Share

  637. PRAKASHAN D, Shrikrishna NS, Byakodi M, Nagamani K, et al
    Gold nanoparticle conjugate-based lateral flow immunoassay (LFIA) for rapid detection of RBD antigen of SARS CoV-2 in clinical samples using smartphone-based application.
    J Med Virol. 2022 Dec 21. doi: 10.1002/jmv.28416.
    >> Share

  638. ALZAHRANI MM, Bamashmous S, Alkharobi H, Alghamdi A, et al
    Mouth Rinses Efficacy on Salivary SARS-CoV-2 Viral Load: A Randomized Clinical Trial.
    J Med Virol. 2022 Dec 17. doi: 10.1002/jmv.28412.
    >> Share

  639. JIANG ML, Xu YP, Wu H, Zhu RN, et al
    Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China.
    J Med Virol. 2022 Dec 16. doi: 10.1002/jmv.28411.
    >> Share

  640. WANG Q, Ye SB, Zhou ZJ, Song AL, et al
    Key mutations in the spike protein of SARS-CoV-2 affecting neutralization resistance and viral internalization.
    J Med Virol. 2022 Dec 15. doi: 10.1002/jmv.28407.
    >> Share

  641. ZHOU C, Wu A, Ye S, Zhou Z, et al
    Possible transmission of COVID-19 epidemic by a dog as a passive mechanical carrier of SARS-CoV-2, Chongqing, China, 2022.
    J Med Virol. 2022 Dec 15. doi: 10.1002/jmv.28408.
    >> Share

  642. LI X, Li T, Chen N, Wang X, et al
    Influence of COVID-19 pandemic on inhaled allergens in children with allergic diseases, Henan, China.
    J Med Virol. 2022 Dec 15. doi: 10.1002/jmv.28409.
    >> Share

  643. ABEYWARDHANA S, Bandaranayake U, Perera DB, Premathilaka M, et al
    In silico study of SARS-CoV-2 Spike protein RBD and human ACE-2 affinity dynamics across variants and Omicron sub-variants.
    J Med Virol. 2022 Dec 15. doi: 10.1002/jmv.28406.
    >> Share

  644. VIETZEN H, Furlano PL, Traugott M, Totschnig D, et al
    The Natural Killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19.
    J Med Virol. 2022 Dec 14. doi: 10.1002/jmv.28404.
    >> Share

  645. AKRAMI S, Montazeri EA, Saki M, Neisi N, et al
    Bacterial profiles and their antibiotic resistance background in superinfections caused by multidrug-resistant bacteria among COVID-19 ICU patients from southwest Iran.
    J Med Virol. 2022 Dec 14. doi: 10.1002/jmv.28403.
    >> Share

  646. HAYES LJ, Uri H, Bojkova D, Cinatl J Jr, et al
    Impact of the COVID-19 pandemic on the circulation of other pathogens in England.
    J Med Virol. 2022 Dec 13. doi: 10.1002/jmv.28401.
    >> Share

  647. CAMACHO J, Albert E, Zulaica J, Alvarez-Rodriguez B, et al
    A Performance Comparison of two (Electro) chemiluminescence Immunoassays for Detection and Quantitation of Serum Anti-Spike Antibodies According to SARS-CoV-2 Vaccination and Infections Status.
    J Med Virol. 2022 Dec 12. doi: 10.1002/jmv.28397.
    >> Share

  648. PANAHI Y, Ghanei M, Rahimi M, Samim A, et al
    Evaluation the efficacy and safety of N-acetylcysteine inhalation spray in controlling the symptoms of patients with COVID-19: An open-label randomized controlled clinical trial.
    J Med Virol. 2022 Dec 10. doi: 10.1002/jmv.28393.
    >> Share

  649. GOEL A, Ray A, Chavan A, Sahni S, et al
    A study on the morbid Histopathological changes in COVID-19 patients with or without comorbidities using minimally invasive tissue sampling.
    J Med Virol. 2022 Dec 8. doi: 10.1002/jmv.28384.
    >> Share

  650. YANG Q, Tang J, Cao J, Liu F, et al
    SARS-CoV-2 infection activates CREB/CBP in cellular cyclic AMP-dependent pathways.
    J Med Virol. 2022 Dec 8. doi: 10.1002/jmv.28383.
    >> Share

  651. YAN Q, Zheng W, Jiang Y, Zhou P, et al
    Transcriptomic reveals the ferroptosis features of host response in a mouse model of Zika virus infection.
    J Med Virol. 2022 Dec 8. doi: 10.1002/jmv.28386.
    >> Share

  652. RIZZO A, Foschi A, Bracchitta F, Faggion I, et al
    Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient.
    J Med Virol. 2022 Dec 7. doi: 10.1002/jmv.28381.
    >> Share

  653. LI M, Hao J, Jiang T, Deng W, et al
    Maternal and neonatal safety of COVID-19 vaccination during peri-pregnancy period: a prospective study.
    J Med Virol. 2022 Dec 7. doi: 10.1002/jmv.28378.
    >> Share

  654. WANG H, Gan M, Wu B, Zeng R, et al
    Humoral and cellular immunity of two-dose inactivated COVID-19 vaccination in Chinese children: a prospective cohort study.
    J Med Virol. 2022 Dec 7. doi: 10.1002/jmv.28380.
    >> Share

  655. LIN-WANG HT, Damiani LP, Farias EDS, Bajgelman MC, et al
    Longitudinal study comparing IgG antibodies induced by heterologous prime-boost COVID-19 vaccine.
    J Med Virol. 2022 Dec 7. doi: 10.1002/jmv.28379.
    >> Share

  656. ZHENG Z, Lu Y, Wang M, Luo Y, et al
    Low COVID-19 Vaccine Coverage and Guardian Acceptance Among Pediatric Transplant Recipients.
    J Med Virol. 2022 Dec 7. doi: 10.1002/jmv.28377.
    >> Share

  657. SCHULTHEISS C, Willscher E, Paschold L, Gottschick C, et al
    Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28364.
    >> Share

  658. KANG SW, Kim JY, Park H, Lim SY, et al
    Comparison of Secondary Attack Rate and Viable Virus Shedding between Patients with SARS-CoV-2 Delta and Omicron Variants: A Prospective Cohort Study.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28369.
    >> Share

  659. SHEN KY, Yang CH, Chen CT, Ho HM, et al
    Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28370.
    >> Share

  660. VIRSEDA-BERDICES A, Concostrina-Martinez L, Martinez-Gonzalez O, Blancas R, et al
    RELATIVE TELOMERE LENGTH IMPACT ON MORTALITY OF COVID-19: SEX DIFFERENCES.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28368.
    >> Share

  661. WOLF JM, Wolf LM, Bello GL, Maccari JG, et al
    Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28366.
    >> Share

  662. LI J, Zheng J, Chen P, Wang B, et al
    Higher SARS-CoV-2 shedding in exhaled aerosol probably contributed to the enhanced transmissibility of Omicron BA.5 subvariant.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28365.
    >> Share

  663. PARKER M, Sawant HB, Flannery T, Tarrant R, et al
    Effect of using a structured pacing protocol on post-exertional symptom exacerbation and health status in a longitudinal cohort with the post-COVID-19 syndrome.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28373.
    >> Share

  664. MOKHTARI MB, Samaniego V, Mokhtari MB, Ishak A, et al
    Relationship of Prior COVID-19 infection and Side Effects of Pfizer-BioNTech Vaccine: Results from a Community Hospital.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28374.
    >> Share

    November 2022
  665. FATMA B, Yohan N, Domitille C, Anne-Laure L, et al
    Early Plasma Interferon-beta Levels as a Predictive Marker of COVID-19 Severe Clinical Events in Adult Patients.
    J Med Virol. 2022 Nov 30. doi: 10.1002/jmv.28361.
    >> Share

  666. LUO D, Li T, Yang X, Ning N, et al
    The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection.
    J Med Virol. 2022 Nov 29. doi: 10.1002/jmv.28359.
    >> Share

  667. MIHAYLOVA A, Lesichkova S, Baleva M, Nikolova-Vlahova M, et al
    DURABILITY OF HUMORAL AND CELL-MEDIATED IMMUNE RESPONSE AFTER SARS-CoV-2 mRNA VACCINE ADMINISTRATION.
    J Med Virol. 2022 Nov 29. doi: 10.1002/jmv.28360.
    >> Share

  668. PARK SH, Hong SH, Kim K, Lee SW, et al
    Non-Pharmaceutical Interventions Reduce the Incidence, and Mortality of COVID-19: A Study based on the Survey from the International COVID-19 Research Network (ICRN).
    J Med Virol. 2022 Nov 29. doi: 10.1002/jmv.28354.
    >> Share

  669. PAN Y, Wang S, Liu G, Wang L, et al
    The third inactivated vaccine booster dramatically enhanced SARS-CoV-2 antibody responses and did not influence the profile of prothrombotic antibody.
    J Med Virol. 2022 Nov 28. doi: 10.1002/jmv.28356.
    >> Share

  670. GHOLAMI M, Zoughi M, Hasanzad M, Larijani B, et al
    Haplotypic variants of COVID-19 related genes are associated with blood pressure and metabolites levels.
    J Med Virol. 2022 Nov 28. doi: 10.1002/jmv.28355.
    >> Share

  671. DU M, Wang R, Yuan J, Lv X, et al
    Trends and disparities in 44 national notifiable infectious diseases in China: an analysis of national surveillance data from 2010 to 2019.
    J Med Virol. 2022 Nov 28. doi: 10.1002/jmv.28353.
    >> Share

  672. YAN H, Zhang R, Yan G, Liu Z, et al
    Production of a versatile SARS-CoV-2 main protease biosensor based on a dimerization-dependent red fluorescent protein.
    J Med Virol. 2022 Nov 24. doi: 10.1002/jmv.28342.
    >> Share

  673. LI K, Shi J, Liu X, Ward MP, et al
    Early warning signals for Omicron outbreaks in China: a retrospective study.
    J Med Virol. 2022 Nov 24. doi: 10.1002/jmv.28341.
    >> Share

  674. JIA C, Zhou Z, Pan W, Zhang P, et al
    Immune Repertoire Sequencing Reveals an Abnormal Adaptive Immune System in COVID-19 Survivors.
    J Med Virol. 2022 Nov 24. doi: 10.1002/jmv.28340.
    >> Share

  675. LIN YF, Wu X, Li Y, Bian J, et al
    Impact of combination preventative interventions on hospitalization and death under the pandemic of SARS-CoV-2 Omicron variant in China.
    J Med Virol. 2022 Nov 23. doi: 10.1002/jmv.28335.
    >> Share

  676. DONG Y, Li X, Li Z, Zhu Y, et al
    Effects of inactivated SARS-CoV-2 vaccination on male fertility: a retrospective cohort study.
    J Med Virol. 2022 Nov 22. doi: 10.1002/jmv.28329.
    >> Share

  677. TAKAKURA K, Suka M, Kajihara M, Koido S, et al
    Clinical features, therapeutic outcomes and recovery period of long COVID.
    J Med Virol. 2022 Nov 22. doi: 10.1002/jmv.28316.
    >> Share

  678. ONG CP, Ye ZW, Tang K, Liang R, et al
    Comparative analysis of SARS-CoV-2 Omicron BA.2.12.1 and BA.5.2 variants.
    J Med Virol. 2022 Nov 21. doi: 10.1002/jmv.28326.
    >> Share

  679. RAHMATI M, Koyanagi A, Banitalebi E, Yon DK, et al
    The effect of SARS-CoV-2 infection on cardiac function in post-COVID-19 survivors: A systematic review and meta-analysis.
    J Med Virol. 2022 Nov 18. doi: 10.1002/jmv.28325.
    >> Share

  680. GAO W, Li Z, Guan Q, Cui W, et al
    Characterisation and analysis of linear epitopes corresponding to SARS-CoV-2 outbreak in Jilin Province, China.
    J Med Virol. 2022 Nov 18. doi: 10.1002/jmv.28323.
    >> Share

  681. DOBROVOLNA M, Brazda V, Warner EF, Bidula S, et al
    Inverted repeats in the monkeypox virus genome are hot spots for mutation.
    J Med Virol. 2022 Nov 18:e28322. doi: 10.1002/jmv.28322.
    >> Share

  682. CHAN CC, Liaw YP
    Letter to the Editor Regarding "The clinical and bioinformatics analysis for the role of antihypertension drugs on mortality among patients with hypertension hospitalized with COVID-19".
    J Med Virol. 2022 Nov 17. doi: 10.1002/jmv.28319.
    >> Share

  683. SMITH H, Mahon A, Moss A, Rao S, et al
    SARS-CoV-2 Infection in Children Evaluated in an Ambulatory Setting During Delta and Omicron Time Periods.
    J Med Virol. 2022 Nov 17. doi: 10.1002/jmv.28318.
    >> Share

  684. ALI AM, Tofiq AM, Rostam HM, Ali KM, et al
    Reply to Letter to the Editor on disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    J Med Virol. 2022 Nov 15. doi: 10.1002/jmv.28313.
    >> Share

  685. SCHLESINGER M, McDonald C, Ahuja A, Canete CA, et al
    GLUCOSE AND MANNOSE ANALOGS INHIBIT KSHV REPLICATION BY BLOCKING N-GLYCOSYLATION AND INDUCING THE UNFOLDED PROTEIN RESPONSE.
    J Med Virol. 2022 Nov 15. doi: 10.1002/jmv.28314.
    >> Share

  686. LIN L, Deng J, Li J, Zheng L, et al
    Pathogenesis and histological changes of nephropathy associated with COVID-19.
    J Med Virol. 2022 Nov 15. doi: 10.1002/jmv.28311.
    >> Share

  687. LOU M, Huang D, Zhou Z, Shi X, et al
    DNA virus oncoprotein HPV18 E7 selectively antagonizes cGAS-STING-triggered innate immune activation.
    J Med Virol. 2022 Nov 15. doi: 10.1002/jmv.28310.
    >> Share

  688. ERGOREN MC, Akan G, Volkan E, Kandemis E, et al
    The "vaccine" hubbub: Viral load comparisons of SARS-CoV-2 Delta and Omicron variants against different vaccine-booster vaccine combinations.
    J Med Virol. 2022 Nov 14. doi: 10.1002/jmv.28309.
    >> Share

  689. ABORODE AT, Huang H, Awuah WA, Mehta A, et al
    Approaching COVID-19 with epidemiological genomic surveillance and the sustainability of biodiversity informatics in Africa.
    J Med Virol. 2022 Nov 13. doi: 10.1002/jmv.28308.
    >> Share

  690. CHEN J, Li F, Tian J, Xie X, et al
    Varicella Zoster Virus Reactivation Following COVID-19 Vaccination in patients with autoimmune inflammatory rheumatic diseases: A cross-sectional Chinese study of 318 cases.
    J Med Virol. 2022 Nov 13. doi: 10.1002/jmv.28307.
    >> Share

  691. REUSCH J, Wagenhauser I, Gabel A, Eggestein A, et al
    Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study.
    J Med Virol. 2022 Nov 11:e28300. doi: 10.1002/jmv.28300.
    >> Share

  692. CHIRUMBOLO S
    The widest use of paracetamol in home therapy might have actually increased the occurrence of severe forms of COVID-19 in Italy, affecting hospitalization and death rates.
    J Med Virol. 2022 Nov 11:e28301. doi: 10.1002/jmv.28301.
    >> Share

  693. YANG Y, Xing H, Zhao Y
    Transplacental transmission of SARS-CoV-2 immunoglobulin G antibody to infants from maternal COVID-19 vaccine immunization before pregnancy.
    J Med Virol. 2022 Nov 11:e28296. doi: 10.1002/jmv.28296.
    >> Share

  694. RAHMATI M, Fatemi R, Yon DK, Lee SW, et al
    The effect of adherence to high-quality dietary pattern on COVID-19 outcomes: A systematic review and meta-analysis.
    J Med Virol. 2022 Nov 11:e28298. doi: 10.1002/jmv.28298.
    >> Share

  695. YE Q, Liu H, Mao J, Shu Q, et al
    Nonpharmaceutical interventions for COVID-19 disrupt the dynamic balance between influenza A virus and human immunity.
    J Med Virol. 2022 Nov 11. doi: 10.1002/jmv.28292.
    >> Share

  696. MOYO E, Moyo P, Mashe T, Dzobo M, et al
    Implementation of Public Health Genomics in Africa: Lessons from the COVID-19 pandemic, challenges, and recommendations.
    J Med Virol. 2022 Nov 11:e28295. doi: 10.1002/jmv.28295.
    >> Share

  697. HAN K, Wang J, Zou Y, Zhang Y, et al
    Association between emphysema and other pulmonary computed tomography patterns in COVID-19 pneumonia.
    J Med Virol. 2022 Nov 10:e28293. doi: 10.1002/jmv.28293.
    >> Share

  698. CHEE YJ, Fan BE, Young BE, Dalan R, et al
    Clinical trials on the pharmacological treatment of long COVID: a systematic review.
    J Med Virol. 2022 Nov 8. doi: 10.1002/jmv.28289.
    >> Share

  699. QIU S, Xu D, Dai J, Zhang L, et al
    Improving the efficiency and biosafety of respiratory syncytial virus identification using a nucleic acid extraction-free reagent.
    J Med Virol. 2022 Nov 7. doi: 10.1002/jmv.28287.
    >> Share

  700. BLANCO S, Aguilar JJ, Spinsanti L, Diaz A, et al
    Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1-S, BBIBP-CorV and Gam-COVID-Vac in an Argentinean cohort.
    J Med Virol. 2022 Nov 7. doi: 10.1002/jmv.28286.
    >> Share


  701. Zhu, C, He, G, Yin, Q, et al. Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge. J Med Virol. 2021;93: 5729- 5741.
    J Med Virol. 2022 Nov 4. doi: 10.1002/jmv.28282.
    >> Share

  702. CAMACHO J, Gimenez E, Albert E, Zulaica J, et al
    Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant.
    J Med Virol. 2022 Nov 4:e28284. doi: 10.1002/jmv.28284.
    >> Share

  703. ZHAO L, Li Y, Yi W, Yan K, et al
    Reply to Chan, et al.
    J Med Virol. 2022 Nov 4. doi: 10.1002/jmv.28283.
    >> Share

  704. LIU C, Zhang J, Zeng Y, Huang C, et al
    Effectiveness of SARS-CoV-2 inactivated vaccine and the correlation to neutralizing antibodies: a test-negative case-control study.
    J Med Virol. 2022 Nov 3. doi: 10.1002/jmv.28280.
    >> Share

  705. LI X, Yin Y, Cui Q, Huang W, et al
    Long-term variations and potency of neutralizing antibodies against Omicron subvariants after CoronaVac inactivated booster: a 7-month follow-up study.
    J Med Virol. 2022 Nov 3. doi: 10.1002/jmv.28279.
    >> Share

  706. HE ST, Qin H, Guan L, Liu K, et al
    Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model.
    J Med Virol. 2022 Nov 3. doi: 10.1002/jmv.28281.
    >> Share

  707. FURUSE Y
    Cartography of SARS-CoV-2 variants based on the susceptibility to therapeutic monoclonal antibodies.
    J Med Virol. 2022 Nov 3. doi: 10.1002/jmv.28275.
    >> Share

  708. SHMUELIAN Z, Warszawer Y, Or O, Arbel-Alon S, et al
    Post-exposure-vaccine-prophylaxis against COVID-19.
    J Med Virol. 2022 Nov 2. doi: 10.1002/jmv.28274.
    >> Share

  709. HALLMANN E, Sikora D, Poniedzialek B, Szymanski K, et al
    IgG autoantibodies against ACE2 in SARS-CoV-2 infected patients.
    J Med Virol. 2022 Nov 2. doi: 10.1002/jmv.28273.
    >> Share

  710. ROSENBAUER J, Stahl-Pehe A, Schlesinger S, Kuss O, et al
    Comments on Rahmati et al., The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol. 2022; 1-16 (doi: 10.1002/jmv.27996).
    J Med Virol. 2022 Nov 2. doi: 10.1002/jmv.28272.
    >> Share

  711. LUCZKOWIAK J, Rivas G, Labiod N, Lasala F, et al
    Cross Neutralization of SARS-CoV-2 Omicron Subvariants after repeated doses of COVID-19 mRNA vaccines.
    J Med Virol. 2022 Nov 1. doi: 10.1002/jmv.28268.
    >> Share

  712. WEI Z, Jiang Y, Zhao G, Li C, et al
    Irradiation accelerates SARS-CoV-2 infection by enhancing sphingolipid metabolism.
    J Med Virol. 2022 Nov 1. doi: 10.1002/jmv.28266.
    >> Share

    October 2022
  713. BARANOVA A, Cao H, Teng S, Zhang F, et al
    A phenome-wide investigation of risk factors for severe COVID-19.
    J Med Virol. 2022 Oct 31. doi: 10.1002/jmv.28264.
    >> Share

  714. HUANG J, Fang Z, Huang L, Fan L, et al
    Effect of COVID-19 vaccination on semen parameters: a systematic review and meta-analysis.
    J Med Virol. 2022 Oct 30. doi: 10.1002/jmv.28263.
    >> Share


  715. Corrigendum.
    J Med Virol. 2022 Oct 29. doi: 10.1002/jmv.28261.
    >> Share

  716. ZHOU Y, Li GX, Zhao TS, Du J, et al
    Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS-CoV-2: a cross-sectional study in Puyang city, China.
    J Med Virol. 2022 Oct 28. doi: 10.1002/jmv.28256.
    >> Share

  717. ROUERS A, Wong N, Goh YS, Torres-Ruesta A, et al
    Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters.
    J Med Virol. 2022 Oct 27. doi: 10.1002/jmv.28258.
    >> Share

  718. MENG W, Guo S, Cao S, Shuda M, et al
    Development and Characterization of a New Monoclonal Antibody against SARS-CoV-2 NSP12.
    J Med Virol. 2022 Oct 21. doi: 10.1002/jmv.28246.
    >> Share

  719. GUO Z, Zhao S, Sun S, He D, et al
    Estimation of the serial interval of monkeypox during the early outbreak in 2022.
    J Med Virol. 2022 Oct 21. doi: 10.1002/jmv.28248.
    >> Share

  720. SHARMA D, Notarte KI, Fernandez RA, Lippi G, et al
    In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    J Med Virol. 2022 Oct 19. doi: 10.1002/jmv.28241.
    >> Share

  721. ZHAO Y, Zhao Y, Zhang Y, Li M, et al
    Association of COVID-19 vaccination before conception with maternal thyroid function during early pregnancy: a single-center study in China.
    J Med Virol. 2022 Oct 19. doi: 10.1002/jmv.28245.
    >> Share

  722. BE S, Celikbilek A, Y K, B I, et al
    Neurological symptoms and neuronal damage markers in acute COVID 19: is there a correlation? A pilot study.
    J Med Virol. 2022 Oct 19. doi: 10.1002/jmv.28240.
    >> Share

  723. HE L, Zhong J, Li G, Lin Z, et al
    Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression system.
    J Med Virol. 2022 Oct 18. doi: 10.1002/jmv.28237.
    >> Share

  724. AL-EMRAN HM, Shaminur Rahman M, Hasan MS, Alam ASMRU, et al
    Microbiome analysis revealing microbial interactions and secondary bacterial infections in COVID-19 patients co-morbidly affected by type 2 diabetes.
    J Med Virol. 2022 Oct 18. doi: 10.1002/jmv.28234.
    >> Share

  725. RAMIREZ-VELEZ R, Olabarrieta-Landa L, Rivera D, Izquierdo M, et al
    Factor Structure of the 10-item CES-D Scale Among Patients with Persistent COVID-19.
    J Med Virol. 2022 Oct 18. doi: 10.1002/jmv.28236.
    >> Share

  726. GELENER P, Demirtas E
    Autoimmune seronegative limbic encephalitis following ChAdOx1-S/nCoV-19 vaccination in a patient with ankylosing spondylitis.
    J Med Virol. 2022 Oct 18. doi: 10.1002/jmv.28235.
    >> Share

  727. ERDIK B
    Antiviral Treatment of COVID-19 is associated with lack of immune response.
    J Med Virol. 2022 Oct 18. doi: 10.1002/jmv.28233.
    >> Share

  728. HORITA N, Fukumoto T
    Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic.
    J Med Virol. 2022 Oct 17. doi: 10.1002/jmv.28231.
    >> Share

  729. FISH CS, Owiti P, Begnel ER, Itell HL, et al
    Comparison of nucleocapsid and spike antibody ELISAs for determining SARS-CoV-2 seropositivity in Kenyan women and infants.
    J Med Virol. 2022 Oct 17. doi: 10.1002/jmv.28221.
    >> Share

  730. WU F, Yuan Y, Li Y, Yin D, et al
    The acceptance of SARS-CoV-2 rapid antigen self-testing: a cross-sectional study in China.
    J Med Virol. 2022 Oct 14. doi: 10.1002/jmv.28227.
    >> Share

  731. ZHOU L, Mo C, Yang Y, Zhou Z, et al
    Characterization and application of a series of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein.
    J Med Virol. 2022 Oct 13. doi: 10.1002/jmv.28225.
    >> Share

  732. WANG M, Liu Z, Wang Z, Li K, et al
    Clinical characteristics of 1139 mild cases of the SARS-CoV-2 Omicron variant infected patients in Shanghai.
    J Med Virol. 2022 Oct 13. doi: 10.1002/jmv.28224.
    >> Share

  733. SHEN S, Rui Y, Wang Y, Su J, et al
    SARS-CoV-2, HIV, HPV: convergent evolution of selective regulation of cGAS-STING signaling.
    J Med Virol. 2022 Oct 13. doi: 10.1002/jmv.28220.
    >> Share

  734. LI L, Cui J, Tang J, Shi J, et al
    High titers of neutralizing antibodies in the blood fail to eliminate SARS-CoV-2 viral RNA in the upper respiratory tract.
    J Med Virol. 2022 Oct 13. doi: 10.1002/jmv.28219.
    >> Share

  735. PISAREVA E, Badiou S, Mihalovicova L, Mirandola A, et al
    Persistence of Neutrophil extracellular traps and anti-cardiolipin auto-antibodies in post-acute phase COVID-19 patients.
    J Med Virol. 2022 Oct 13. doi: 10.1002/jmv.28209.
    >> Share

  736. C AM, Singh AK, Roy P, Ravichandran M, et al
    Long COVID following Omicron wave in Eastern India - A retrospective cohort study.
    J Med Virol. 2022 Oct 12. doi: 10.1002/jmv.28214.
    >> Share

  737. NIRANJI SS, Amin Al-Jaf SM
    In response to: Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    J Med Virol. 2022 Oct 12. doi: 10.1002/jmv.28213.
    >> Share

  738. LI X, Yuan H, Li X, Wang H, et al
    Spike protein mediated membrane fusion during SARS-CoV-2 infection.
    J Med Virol. 2022 Oct 12. doi: 10.1002/jmv.28212.
    >> Share

  739. GAHUKAR AM, Khairnar K
    Omicron variant of SARS-CoV-2: A pandemic of global concern warrants a cautious approach.
    J Med Virol. 2022 Oct 12. doi: 10.1002/jmv.28211.
    >> Share

  740. ZHANG Y, Ndzouboukou JB, Lin X, Hou H, et al
    SARS-CoV-2 evolves to reduce but not abolish neutralizing action.
    J Med Virol. 2022 Oct 11. doi: 10.1002/jmv.28207.
    >> Share

  741. MUKHERJEE AG, Wanjari UR, Kannampuzha S, Das S, et al
    The pathophysiological and immunological background of the monkeypox virus infection: An update.
    J Med Virol. 2022 Oct 11. doi: 10.1002/jmv.28206.
    >> Share

  742. YEUNG SLA, Wong THT, He B, Luo S, et al
    Does ACE2 mediate the detrimental effect of exposures related to COVID-19 risk: A Mendelian randomization investigation.
    J Med Virol. 2022 Oct 10. doi: 10.1002/jmv.28205.
    >> Share

  743. WANG P, Xu Y, Zhe SU, Xie C, et al
    Impact of COVID-19 Pandemic on Influenza virus Prevalence in Children in Sichuan, China.
    J Med Virol. 2022 Oct 10. doi: 10.1002/jmv.28204.
    >> Share

  744. RENGASAMY KR
    Will Monkeypox Outbreak mirror COVID-19 or AIDs?
    J Med Virol. 2022 Oct 10. doi: 10.1002/jmv.28202.
    >> Share

  745. CAMP JV, Redlberger-Fritz M
    Increased cases of Influenza C virus in children and adults in Austria, 2022.
    J Med Virol. 2022 Oct 9. doi: 10.1002/jmv.28201.
    >> Share

  746. MIGUERES M, Chapuy-Regaud S, Miedouge M, Jamme T, et al
    Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infection.
    J Med Virol. 2022 Oct 7. doi: 10.1002/jmv.28200.
    >> Share

  747. BARANOVA A, Xu Y, Cao H, Zhang F, et al
    Associations between pulse rate and COVID-19.
    J Med Virol. 2022 Oct 6. doi: 10.1002/jmv.28194.
    >> Share

  748. MIRSHARIF ES, Chenary MR, Bozorgmehr M, Mohammadi S, et al
    Immunophenotyping Characteristics of COVID-19 Patients: Peripheral Blood CD8+ HLA-DR+ T Cells as a Biomarker for Mortality Outcome.
    J Med Virol. 2022 Oct 3. doi: 10.1002/jmv.28192.
    >> Share

  749. VALENTINA M, Alessandro CL, Francesca C, Silvia R, et al
    Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents.
    J Med Virol. 2022 Oct 2. doi: 10.1002/jmv.28186.
    >> Share

    September 2022
  750. GUNELL M, Rantasarkka K, Arjonen R, Sanden A, et al
    Clinical evaluation of an automated, rapid mariPOC(R) antigen test in screening of symptomatics and asymptomatics for SARS-CoV-2 infection.
    J Med Virol. 2022 Sep 30. doi: 10.1002/jmv.28189.
    >> Share

  751. XU W, Song D, Liu J, Han X, et al
    Development of chemiluminescent lab-on-fiber immunosensor for rapid point-of-care testing of anti-SARS-CoV-2 antibodies and evaluation of longitudinal immune response kinetics following three-dose inactivation virus vaccination.
    J Med Virol. 2022 Sep 30. doi: 10.1002/jmv.28190.
    >> Share

  752. YEO YH, Wang M, He X, Lv F, et al
    Excess risk for acute myocardial infarction mortality during the COVID-19 pandemic.
    J Med Virol. 2022 Sep 29. doi: 10.1002/jmv.28187.
    >> Share

  753. SRIRAMAN K, Shaikh A, Vaswani S, Mestry T, et al
    Impact of COVID-19 vaccination on transmission risk of breakthrough infections: Lessons from Adapted N95 Mask Sampling for Emerging Variants and Interventions.
    J Med Virol. 2022 Sep 29. doi: 10.1002/jmv.28188.
    >> Share

  754. NAGASAWA M, Kato T, Yamaguchi Y, Sugita Y, et al
    Rapid decrease of nasopharyngeal SARS-Co-V2 antigen in an outbreak of the Omicron strain.
    J Med Virol. 2022 Sep 29. doi: 10.1002/jmv.28179.
    >> Share

  755. YANG J, Song H, Hao X
    Whole-transcriptome sequencing data reveals a disparate cognitive and immune signature in COVID-19 patients with and without dementia.
    J Med Virol. 2022 Sep 27. doi: 10.1002/jmv.28177.
    >> Share

  756. SU J, Shen S, Hu Y, Chen S, et al
    SARS-CoV-2 ORF3a inhibits cGAS-STING-mediated autophagy flux and antiviral function.
    J Med Virol. 2022 Sep 26. doi: 10.1002/jmv.28175.
    >> Share

  757. ZHOU J, Liu Z, Zhang G, Xu W, et al
    Development of variant-proof SARS-CoV-2, pan-sarbecovirus and pan-beta-coronavirus vaccines.
    J Med Virol. 2022 Sep 25. doi: 10.1002/jmv.28172.
    >> Share

  758. HANAFUSA M, Nawa N, Goto Y, Kawahara T, et al
    Effectiveness of remdesivir with corticosteroids for COVID-19 patients in intensive care unit: a hospital-based observational study.
    J Med Virol. 2022 Sep 23. doi: 10.1002/jmv.28168.
    >> Share

  759. MESSALI S, Bugatti A, Filippini F, Caruso A, et al
    Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host.
    J Med Virol. 2022 Sep 22. doi: 10.1002/jmv.28167.
    >> Share

  760. SILVA MFS, Pinto ACMD, Oliveira FCE, Caetano LF, et al
    Antibody response six months after the booster dose of Pfizer in previous recipients of CoronaVac.
    J Med Virol. 2022 Sep 22. doi: 10.1002/jmv.28169.
    >> Share

  761. FAVRESSE J, Gillot C, Bayart JL, David C, et al
    Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster.
    J Med Virol. 2022 Sep 21. doi: 10.1002/jmv.28164.
    >> Share

  762. DURAND GA, Amroun A, Grard G, Badaut C, et al
    Positive SARS-CoV-2 RT-qPCR of a nasal swab spot after 30 days of conservation on filter paper at room temperature.
    J Med Virol. 2022 Sep 21. doi: 10.1002/jmv.28165.
    >> Share

  763. VEGA-RODRIGUEZ W, Ly H
    GETTING AHEAD OF MONKEYPOX: Learning from the COVID-19 pandemic experience to prevent the potentially new monkeypox pandemic.
    J Med Virol. 2022 Sep 21. doi: 10.1002/jmv.28146.
    >> Share

  764. KONG W, Zhong Q, Chen M, Yu P, et al
    Ad5-nCoV booster and Omicron variant breakthrough infection following two doses of inactivated vaccine elicit comparable antibody levels against Omicron variants.
    J Med Virol. 2022 Sep 20. doi: 10.1002/jmv.28163.
    >> Share

  765. KRISHNAMOORTHY S, Li GH, Cheung CL
    Transcriptome-wide Summary Data based Mendelian Randomization analysis reveals 38 novel genes associating with Severe COVID-19.
    J Med Virol. 2022 Sep 20. doi: 10.1002/jmv.28162.
    >> Share

  766. TAN Y, Lu S, Wang B, Duan X, et al
    Single-cell transcriptome atlas reveals protective characteristics of COVID-19 mRNA vaccine.
    J Med Virol. 2022 Sep 19. doi: 10.1002/jmv.28161.
    >> Share

  767. QIU X, Liu Y, Sha A
    SARS-CoV-2 and Natural Infection in Animals.
    J Med Virol. 2022 Sep 19. doi: 10.1002/jmv.28147.
    >> Share

  768. BOYTZ R, Slabicki M, Ramaswamy S, Patten JJ, et al
    Anti-SARS-CoV-2 Activity of Targeted Kinase Inhibitors: Repurposing Clinically Available Drugs for COVID-19 Therapy.
    J Med Virol. 2022 Sep 18. doi: 10.1002/jmv.28157.
    >> Share

  769. CECCARELLI G, d'Ettorre G, Russo A, Fabris S, et al
    SARS-CoV-2 pandemic, influenza, and influenza-like illness epidemics: Allies or enemies?
    J Med Virol. 2022 Sep 17. doi: 10.1002/jmv.28148.
    >> Share

  770. DESINGU PA, Nagarajan K
    Unveiling HERV-K113-ENV as SARS-CoV-2 severity admissible biomarker by mining transcriptome data.
    J Med Virol. 2022 Sep 16. doi: 10.1002/jmv.28149.
    >> Share

  771. LI Z, Yong H, Wang W, Gao Y, et al
    GSK3326595 is a promising drug to prevent SARS-CoV-2 Omicron and other variants infection by inhibiting ACE2-R671 di-methylation.
    J Med Virol. 2022 Sep 16. doi: 10.1002/jmv.28158.
    >> Share

  772. CENAT JM, Noorishad PG, Moshirian Farahi SMM, Darius WP, et al
    COVID-19 Vaccine Hesitancy and Related Factors in Canada: A Systematic Review and Meta-analysis.
    J Med Virol. 2022 Sep 16. doi: 10.1002/jmv.28156.
    >> Share

  773. LI XK, Tu B, Zhang XA, Xu W, et al
    Dysregulation of glutamine/glutamate metabolism in COVID-19 patients: a metabolism study in African population and mini meta-analysis.
    J Med Virol. 2022 Sep 16. doi: 10.1002/jmv.28150.
    >> Share

  774. KLOPFENSTEIN T, Gendrin V, Zayet S
    "Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study": Author's reply.
    J Med Virol. 2022 Sep 15. doi: 10.1002/jmv.28151.
    >> Share

  775. LAN Q, Wang L, Jiao F, Lu L, et al
    Pan-coronavirus fusion inhibitors to combat COVID-19 and other emerging coronavirus infectious diseases.
    J Med Virol. 2022 Sep 13. doi: 10.1002/jmv.28143.
    >> Share

  776. CALABRETTO M, D'Alisa R, Faraone S, Mazzuti L, et al
    DETECTION OF SARS-COV-2 RNA AND ANTIBODIES IN BREAST MILK OF INFECTED MOTHERS.
    J Med Virol. 2022 Sep 13. doi: 10.1002/jmv.28142.
    >> Share

  777. FRYE CJ, Shine M, Makowski JA, Kensinger AH, et al
    Bioinformatics Analysis of the s2m Mutations within the SARS-CoV-2 Omicron Lineages.
    J Med Virol. 2022 Sep 13. doi: 10.1002/jmv.28141.
    >> Share

  778. ZHOU Y, Zhi H, Teng Y
    The outbreak of SARS-CoV-2 Omicron lineages, immune escape and vaccine effectivity.
    J Med Virol. 2022 Sep 12. doi: 10.1002/jmv.28138.
    >> Share

  779. LIANG LG, Zhu MJ, He R, Shi DR, et al
    Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, Influenza A and B.
    J Med Virol. 2022 Sep 11. doi: 10.1002/jmv.28139.
    >> Share

  780. QUEROMES G, Frobert E, Bouscambert-Duchamp M, Oblette A, et al
    Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: the example of SARS-CoV-2 and monkeypox virus.
    J Med Virol. 2022 Sep 11. doi: 10.1002/jmv.28126.
    >> Share

  781. JIANG W, Johnson D, Adekunle R, Heather H, et al
    COVID-19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity.
    J Med Virol. 2022 Sep 10. doi: 10.1002/jmv.28134.
    >> Share

  782. LI Y, Yang J, Shen S, Wang W, et al
    SARS-CoV-2-encoded Inhibitors of Human LINE-1 Retrotransposition.
    J Med Virol. 2022 Sep 9. doi: 10.1002/jmv.28135.
    >> Share

  783. MARCHI L, Vidiri A, Fera EA, Pallottini M, et al
    SARS-CoV-2 IgG "heritage" in newborn: a credit of maternal natural infection.
    J Med Virol. 2022 Sep 7. doi: 10.1002/jmv.28133.
    >> Share

  784. CELIK E, Ozcan G, Vatansever C, Paerhati E, et al
    Alterations in Vaginal Microbiota among Pregnant Women with COVID-19.
    J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28132.
    >> Share

  785. RZYMSKI P, Kasianchuk N, Sikora D, Poniedzialek B, et al
    COVID-19 Vaccinations and Rates of Infections, Hospitalizations, ICU Admissions, and Deaths in Europe during SARS-CoV-2 Omicron wave in the first quarter of 2022.
    J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28131.
    >> Share

  786. FAIZO AA, Qashqari FS, El-Kafrawy SA, Barasheed O, et al
    A Potential Association between Obesity and Reduced Effectiveness of COVID-19 Vaccine-Induced Neutralizing Humoral Immunity.
    J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28130.
    >> Share

  787. ABDALLA M, El-Arabey AA, Gai Z
    Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome.
    J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28128.
    >> Share

  788. AKASH S, Rahman MM, Islam MR, Sharma R, et al
    Emerging global concern of Langya Henipavirus: Pathogenicity, Virulence, Genomic features, and Future perspectives.
    J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28127.
    >> Share

  789. SCARPA F, Sanna D, Azzena I, Giovanetti M, et al
    On the SARS-CoV-2 BA.2.75 variant: a genetic and structural point of view.
    J Med Virol. 2022 Sep 4. doi: 10.1002/jmv.28119.
    >> Share

  790. NICOT F, Tremeaux P, Latour J, Nicolas J, et al
    WHOLE GENOME SEQUENCING OF SARS-CoV-2: COMPARISON OF TARGET CAPTURE AND AMPLICON SINGLE MOLECULAR REAL TIME SEQUENCING PROTOCOLS.
    J Med Virol. 2022 Sep 3. doi: 10.1002/jmv.28123.
    >> Share

  791. ARISH M, Qian W, Narasimhan H, Sun J, et al
    COVID-19 immunopathology: From acute diseases to chronic sequelae.
    J Med Virol. 2022 Sep 3. doi: 10.1002/jmv.28122.
    >> Share

  792. WETTSTEIN L, Immenschuh P, Weil T, Conzelmann C, et al
    Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.
    J Med Virol. 2022 Sep 3. doi: 10.1002/jmv.28124.
    >> Share

  793. YU T, Liu F, Yi N, Yin H, et al
    Evaluating agreement in different diagnosis methods is necessary.
    J Med Virol. 2022 Sep 2. doi: 10.1002/jmv.28117.
    >> Share

  794. WANG C, Liu B, Zhang S, Huang N, et al
    Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: a world-wide review.
    J Med Virol. 2022 Sep 2. doi: 10.1002/jmv.28118.
    >> Share

  795. WANG Q, Ye SB, Zhou ZJ, Li JY, et al
    Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants.
    J Med Virol. 2022 Sep 2. doi: 10.1002/jmv.28116.
    >> Share

    August 2022
  796. KAYA Y, Gulcu O, Aksakal E, Kalkan K, et al
    A Significant Predictor of In-Hospital and Long-term Mortality and Progression In COVID-19 Patients: The End-Stage Liver Disease (MELD) Score Model.
    J Med Virol. 2022 Aug 31. doi: 10.1002/jmv.28109.
    >> Share

  797. BARANOVA A, Cao H, Zhang F
    Causal Effect of COVID-19 on Alzheimer's Disease: A Mendelian Randomization Study.
    J Med Virol. 2022 Aug 30. doi: 10.1002/jmv.28107.
    >> Share

  798. GENG Y, Wang Y
    Stability and transmissibility of SARS-CoV-2 in the environment.
    J Med Virol. 2022 Aug 30. doi: 10.1002/jmv.28103.
    >> Share

  799. YAO Y, Song H, Zhang F, Liu J, et al
    Genetic predisposition to blood cell indices in relation to severe COVID-19.
    J Med Virol. 2022 Aug 29. doi: 10.1002/jmv.28104.
    >> Share

  800. COLSON P, Gautret P, Delerce J, Chaudet H, et al
    The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule.
    J Med Virol. 2022 Aug 28. doi: 10.1002/jmv.28102.
    >> Share

  801. LIU S, Cai J, Li Y, Ying L, et al
    Outbreak of acute respiratory disease caused by human adenovirus type 7 and Human Coronavirus-229E in Zhejiang Province, China.
    J Med Virol. 2022 Aug 28. doi: 10.1002/jmv.28101.
    >> Share

  802. XIE J, Klemsz MJ, Kacena MA, Sandusky G, et al
    Inhibition of MEK signaling prevents SARS-CoV2-induced lung damage and improves the survival of infected mice.
    J Med Virol. 2022 Aug 28. doi: 10.1002/jmv.28094.
    >> Share

  803. GHANG B, Kim S, Kim J
    Autoimmune rheumatic disease after SARS-CoV-2 vaccination.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28092.
    >> Share

  804. CAO H, Baranova A, Wei X, Wang C, et al
    Bidirectional causal associations between type 2 diabetes and COVID-19.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28100.
    >> Share

  805. SALIMIAN J, Ahmadi A, Amani J, Olad G, et al
    Safety and Immunogenicity of a Recombinant Receptor Binding Domain-Based Protein Subunit Vaccine (Noora Vaccine) Against COVID-19 in Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28097.
    >> Share

  806. ALI AM, Tofiq AM, Rostam HM, Ali KM, et al
    Disease Severity and Efficacy of Homologous Vaccination Among Patients Infected with SARS-CoV-2 Delta or Omicron VOCs, Compared to Unvaccinated using Main Biomarkers.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28098.
    >> Share

  807. LIU H, Chang S, Chen S, Du Y, et al
    Highly sensitive and rapid detection of SARS-CoV-2 via a portable CRISPR-Cas13a-based lateral flow assay.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28096.
    >> Share

  808. PATERSON C, Davis D, Roche M, Bissett B, et al
    What are the long-term holistic health consequences of COVID-19 among survivors? An umbrella systematic review.
    J Med Virol. 2022 Aug 24. doi: 10.1002/jmv.28086.
    >> Share

  809. MENG Y, Zeng F, Sun H, Li Y, et al
    Clinical characteristics and outcomes of patients with COVID-19 and psoriasis.
    J Med Virol. 2022 Aug 24. doi: 10.1002/jmv.28085.
    >> Share

  810. DING C, Ni S, Zhang X, Xie J, et al
    Evaluation of humoral immune responses induced by different SARS-CoV-2 spike trimers from wild-type and emerging variants with individual, sequential, and combinational delivered strategies.
    J Med Virol. 2022 Aug 19. doi: 10.1002/jmv.28081.
    >> Share

  811. DE MICHELENA P, Olea B, Torres I, Gonzalez-Candelas F, et al
    SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2.
    J Med Virol. 2022 Aug 19. doi: 10.1002/jmv.28079.
    >> Share

  812. MA Z, Mao Y, Wang Y, Duan Z, et al
    Suicidal ideation and attempted suicide among cancer patients during the COVID-19 pandemic.
    J Med Virol. 2022 Aug 18. doi: 10.1002/jmv.28076.
    >> Share

  813. ALI MA, Zhang GF, Hu C, Yuan B, et al
    Ultra-Rapid and Ultra-Sensitive Detection of SARS-CoV-2 Antibodies in COVID-19 Patients via A 3D-Printed Nanomaterial-Based Biosensing Platform.
    J Med Virol. 2022 Aug 18. doi: 10.1002/jmv.28075.
    >> Share

  814. LIU H, Li Q, Xiang Y, Li H, et al
    An Outbreak of Acute Respiratory Disease Caused by HAdV-55 in Beijing, China, 2020.
    J Med Virol. 2022 Aug 18. doi: 10.1002/jmv.28074.
    >> Share

  815. CUI A, Xie Z, Xu J, Hu K, et al
    Comparative analysis of the clinical and epidemiological characteristics of human influenza virus vs. human respiratory syncytial virus vs. human metapneumovirus infection in nine provinces of China during 2009-2021.
    J Med Virol. 2022 Aug 18. doi: 10.1002/jmv.28073.
    >> Share

  816. TAO SS, Wang XY, Yang XK, Liu YC, et al
    COVID-19 and inflammatory bowel disease crosstalk: from emerging association to clinical proposal.
    J Med Virol. 2022 Aug 16. doi: 10.1002/jmv.28067.
    >> Share

  817. MOHEBI L, Karami H, Mirsalehi N, Ardestani NH, et al
    A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.
    J Med Virol. 2022 Aug 12. doi: 10.1002/jmv.28065.
    >> Share

  818. YU W, Guo Y, Zhang S, Kong Y, et al
    Proportion of asymptomatic infection and non-severe disease caused by SARS-CoV-2 Omicron variant: a systematic review.
    J Med Virol. 2022 Aug 12. doi: 10.1002/jmv.28066.
    >> Share

  819. GEISEN UM, Rose R, Neumann F, Ciripoi M, et al
    The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFalpha blockade.
    J Med Virol. 2022 Aug 9. doi: 10.1002/jmv.28063.
    >> Share

  820. THAKUR N, Das S, Kumar S, Maurya VK, et al
    Tracing the origin of Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2): A systematic review and narrative synthesis.
    J Med Virol. 2022 Aug 9. doi: 10.1002/jmv.28060.
    >> Share

  821. JIA M, Wang X, Gong W, Zhong J, et al
    Humoral responses after inactivated COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infection: A prospective cohort study.
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28055.
    >> Share

  822. CHEUNG PH, Ye ZW, Lui WY, Ong CP, et al
    Production of single-cycle infectious SARS-CoV-2 through a trans-complemented replicon.
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28057.
    >> Share

  823. INFANTINO M, Manfredi M, Alessio MG, Previtali G, et al
    CLINICAL UTILITY OF CIRCULATING CALPROTECTIN TO ASSIST PREDICTION AND MONITORING OF COVID-19 SEVERITY: AN ITALIAN STUDY.
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28056.
    >> Share

  824. KUMBHAKAR R, Neradilek M, Barnabas RV, Stewart J, et al
    Using Time Weighted Average Change from Baseline of SARS-CoV-2 Viral Load to Assess Impact of Hydroxychloroquine (HCQ) as Post-exposure Prophylaxis and Early Treatment for COVID-19.
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28054.
    >> Share

  825. WANG H, Guo S, Yang H
    Rapid quantitative monitoring of SARS-CoV-2 spike protein mediated syncytia formation using split NanoLuc.
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28053.
    >> Share

  826. ELBAYIYEV S, Simsek GK, Ceran B, Akin MS, et al
    Could red cell distribution width be used for predicting cardiac injury in neonates with COVID-19?
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28050.
    >> Share

  827. ZOU L, Zhang H, Zheng Z, Jiang Y, et al
    Serosurvey in SARS-CoV-2 inactivated vaccine-elicited neutralizing antibodies against authentic SARS-CoV-2 and its viral variants.
    J Med Virol. 2022 Aug 5. doi: 10.1002/jmv.28049.
    >> Share

  828. ZHANG H, Ding Q, Yuan J, Han F, et al
    Susceptibility to mice and potential evolutionary characteristics of porcine deltacoronavirus.
    J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28048.
    >> Share


  829. Corrigendum.
    J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28046.
    >> Share

  830. SUNTRONWONG N, Kanokudom S, Auphimai C, Assawakosri S, et al
    Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination.
    J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28044.
    >> Share


  831. Corrigendum.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28043.
    >> Share

  832. LIM CC, Leeu JJ, Mok IY, Tan HZ, et al
    Influenza Vaccine Awareness and Acceptance in Kidney Disease during the Corononavirus Disease 2019 pandemic.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28039.
    >> Share

  833. KOJIMA Y, Nakakubo S, Kamada K, Yamashita Y, et al
    Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28037.
    >> Share

  834. LIANG W, Wang S, Wang H, Li X, et al
    When 3D genome technology meets viral infection, including SARS-CoV-2.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28040.
    >> Share

    July 2022
  835. PENG P, Deng H, Li Z, Chen Y, et al
    Distinct immune responses in the early phase to natural SARS-CoV-2 infection or vaccination.
    J Med Virol. 2022 Jul 29. doi: 10.1002/jmv.28034.
    >> Share

  836. MURPHY H, Ly H
    What are the levels of risk of humans contracting SARS-CoV-2 from pets and vice versa?
    J Med Virol. 2022 Jul 29. doi: 10.1002/jmv.28035.
    >> Share

  837. ALEXIEV I, Giovanetti M, Cella E, Ivanov I, et al
    Initial Introduction and Spread of the SARS-CoV-2 AY.4.2.1 Delta Variant in Bulgaria, a Genomic Insight.
    J Med Virol. 2022 Jul 28. doi: 10.1002/jmv.28033.
    >> Share

  838. ZHANG GF, Meng W, Chen L, Ding L, et al
    Neutralizing Antibodies to SARS-CoV-2 Variants of Concern Including Delta and Omicron in Subjects Receiving mRNA-1273, BNT162b2 and Ad26.COV2.S Vaccines.
    J Med Virol. 2022 Jul 28. doi: 10.1002/jmv.28032.
    >> Share

  839. KOJIMA N, Desai V, Klausner JD
    Distributing Effective SARS-CoV-2 Medicines in a Timely Manner.
    J Med Virol. 2022 Jul 26. doi: 10.1002/jmv.28030.
    >> Share

  840. POURAKBARI B, Mirbeyk M, Mahmoudi S, Sadeghi RH, et al
    Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran.
    J Med Virol. 2022 Jul 26. doi: 10.1002/jmv.28029.
    >> Share

  841. JANG EJ, Choe YJ, Yun GW, Wang S, et al
    Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study.
    J Med Virol. 2022 Jul 25. doi: 10.1002/jmv.28026.